7Baggers

Exelixis, Inc
(NASDAQ:EXEL) 

EXEL stock logo

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who receiv...

Founded: 1994
Full Time Employees: 617
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-01-02 2025-12-31 2025-10-03 2025-07-04 2025-04-04 2025-01-03 2024-09-30 2024-09-27 2024-06-30 2024-06-28 2024-03-31 2024-03-29 2023-12-31 2023-12-29 2023-09-30 2023-09-29 2023-06-30 2023-03-31 2022-12-31 2022-12-30 2022-09-30 2022-07-01 2022-06-30 2022-04-01 2022-03-31 2021-12-31 2021-10-01 2021-09-30 2021-07-02 2021-06-30 2021-04-02 2021-03-31 2021-01-01 2020-12-31 2020-10-02 2020-09-30 2020-07-03 2020-06-30 2020-04-03 2020-03-31 2020-01-03 2019-09-30 2019-09-27 2019-06-30 2019-06-28 2019-03-31 2019-03-29 2018-12-31 2018-12-28 2018-09-30 2018-09-28 2018-06-30 2018-06-29 2018-03-31 2018-03-30 2017-12-31 2017-12-29 2017-09-30 2017-09-29 2017-06-30 2017-03-31 2016-12-31 2016-12-30 2016-09-30 2016-07-01 2016-06-30 2016-04-01 2016-03-31 2016-01-01 2015-10-02 2015-09-30 2015-07-03 2015-06-30 2015-04-03 2015-03-31 2014-12-31 2014-09-30 2014-09-26 2014-06-30 2014-06-27 2014-03-31 2014-03-28 2013-12-31 2013-09-30 2013-09-27 2013-06-30 2013-06-28 2013-03-31 2013-03-29 2012-12-31 2012-12-28 2012-09-30 2012-06-30 2012-06-29 2012-03-31 2012-03-30 2011-12-31 2011-12-30 2011-09-30 2011-07-01 2011-06-30 2011-04-01 2011-03-31 2010-12-31 2010-10-01 2010-09-30 2010-07-02 2010-06-30 2010-04-02 2010-03-31 2010-01-01 2009-12-31 2009-10-02 2009-09-30 2009-07-03 2009-06-30 2009-04-03 2009-03-31 2009-01-02 2008-09-30 2008-09-26 2008-06-30 2008-06-27 2008-03-31 2008-03-28 2007-12-31 2007-12-28 2007-09-30 2007-09-28 2007-06-30 2007-06-29 2007-03-31 2007-03-30 2006-12-31 2006-12-29 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2004-09-30 2004-06-30 2004-03-31 2003-12-31 2003-09-30 2003-06-30 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-01-02 2025-10-03 2025-09-30 2025-07-04 2025-06-30 2025-04-04 2025-03-31 2025-01-03 2024-12-31 2024-09-30 2024-09-27 2024-06-30 2024-06-28 2024-03-31 2024-03-29 2023-12-31 2023-12-29 2023-09-30 2023-09-29 2023-06-30 2023-03-31 2022-12-31 2022-12-30 2022-09-30 2022-07-01 2022-06-30 2022-04-01 2022-03-31 2021-12-31 2021-10-01 2021-09-30 2021-07-02 2021-06-30 2021-04-02 2021-03-31 2021-01-01 2020-12-31 2020-10-02 2020-09-30 2020-07-03 2020-06-30 2020-04-03 2020-03-31 2020-01-03 2019-12-31 2019-09-30 2019-09-27 2019-06-30 2019-06-28 2019-03-31 2019-03-29 2018-12-31 2018-12-28 2018-09-30 2018-09-28 2018-06-30 2018-06-29 2018-03-31 2018-03-30 2017-12-31 2017-12-29 2017-09-30 2017-09-29 2017-06-30 2017-03-31 2016-12-31 2016-12-30 2016-09-30 2016-07-01 2016-06-30 2016-04-01 2016-03-31 2016-01-01 2015-12-31 2015-10-02 2015-09-30 2015-07-03 2015-06-30 2015-04-03 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-06-27 2014-03-31 2014-03-28 2013-12-31 2013-09-30 2013-09-27 2013-06-30 2013-06-28 2013-03-31 2013-03-29 2012-12-31 2012-12-28 2012-09-30 2012-06-30 2012-06-29 2012-03-31 2012-03-30 2011-12-31 2011-12-30 2011-09-30 2011-07-01 2011-06-30 2011-04-01 2011-03-31 2010-12-31 2010-10-01 2010-09-30 2010-07-02 2010-06-30 2010-04-02 2010-03-31 2010-01-01 2009-12-31 2009-10-02 2009-09-30 2009-07-03 2009-06-30 2009-04-03 2009-03-31 2009-01-02 2008-12-31 2008-09-30 2008-09-26 2008-06-30 2008-06-27 2008-03-31 2008-03-28 2007-12-31 2007-12-28 2007-09-30 2007-09-28 2007-06-30 2007-06-29 2007-03-31 2007-03-30 2006-12-31 2006-12-29 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2004-09-30 2004-06-30 2004-03-31 2003-12-31 2003-09-30 2003-06-30 
                                                                                                                                                                
        assets
                                                                                                                                                                
        current assets:
                                                                                                                                                                
        cash and cash equivalents
      482,488,000 376,300,000 376,300,000 164,433,000 164,433,000 183,752,000 183,752,000 217,374,000 217,374,000 258,346,000 258,346,000 198,459,000 198,459,000 259,561,000 259,561,000 262,994,000 262,994,000 396,859,000 396,859,000 464,480,000 540,597,000 501,195,000 501,195,000 675,286,000 627,000,000 627,000,000 723,269,000 723,269,000 647,169,000 567,325,000 567,325,000 492,462,000 492,462,000 370,209,000 370,209,000 319,217,000 319,217,000 334,046,000 334,046,000 527,143,000 527,143,000 357,340,000 357,340,000 266,501,000 266,501,000 242,317,000 242,317,000 369,789,000 369,789,000 373,937,000 373,937,000 314,775,000 314,775,000 353,623,000 353,623,000 248,407,000 248,407,000 232,331,000 232,331,000 183,164,000 183,164,000 149,357,000 149,357,000 135,212,000 183,179,000 151,686,000 151,686,000 111,219,000 129,827,000 129,827,000 276,882,000 276,882,000 141,634,000 141,634,000 145,642,000 145,642,000 61,949,000 61,949,000 84,987,000 84,987,000 80,395,000 100,065,000 147,340,000 147,340,000 157,539,000 157,539,000 103,978,000 92,016,000 92,016,000 131,774,000 131,774,000 171,232,000 171,232,000 170,069,000 170,069,000 308,805,000 68,140,000 68,140,000 70,466,000 70,466,000 74,257,000 74,257,000 66,211,000 75,280,000 75,280,000 202,051,000 202,051,000 97,440,000 95,342,000 95,342,000 157,202,000 157,202,000 58,292,000 58,292,000 86,796,000 86,796,000 170,570,000 170,570,000 152,912,000 152,912,000 201,425,000 201,425,000 247,698,000 247,698,000 64,230,000 64,230,000 75,047,000 75,047,000 121,883,000 121,883,000 135,457,000 135,457,000 141,326,000 141,326,000 105,607,000 105,607,000 143,839,000 143,839,000 123,369,000 123,369,000 55,700,000 86,017,000 140,101,000 96,471,000 90,010,000 104,821,000 61,384,000 78,105,000 47,993,000 38,924,000 80,323,000  55,056,000 68,572,000 
        marketable securities
      576,603,000 612,235,000 612,235,000 626,665,000 626,665,000 847,564,000 847,564,000 893,902,000 893,902,000 930,815,000 930,815,000                                                                                     163,542,000 138,901,000 138,901,000 172,979,000 172,979,000 120,005,000 120,005,000 156,947,000 187,502,000 187,502,000 99,621,000 99,621,000 65,224,000 71,929,000 71,929,000 55,593,000 55,593,000 94,243,000 94,243,000 116,290,000 116,290,000 115,737,000 115,737,000 42,993,000 42,993,000 4,044,000 4,044,000   26,159,000 26,159,000 61,634,000 61,634,000 79,509,000 79,509,000 105,153,000 105,153,000 95,965,000 95,965,000 78,236,000 78,236,000 83,636,000 83,636,000 55,516,000 55,516,000 15,965,000 30,145,000 36,995,000 67,307,000           
        trade receivables
      286,916,000 309,725,000 309,725,000 292,354,000 292,354,000 281,637,000 281,637,000 265,437,000 265,437,000 269,706,000 269,706,000 396,584,000 396,584,000 240,577,000 240,577,000 237,407,000 237,407,000 248,113,000 248,113,000 232,818,000 233,923,000 214,784,000 214,784,000 215,015,000 235,400,000 235,400,000 190,614,000 190,614,000 282,650,000 179,493,000 179,493,000 171,753,000 171,753,000 177,673,000 177,673,000 160,875,000 160,875,000 166,138,000 166,138,000 121,080,000 121,080,000 137,338,000 137,338,000 119,073,000 119,073,000 169,788,000 169,788,000 97,541,000 97,541,000 107,670,000 107,670,000 162,771,000 162,771,000                                                                                                      
        inventory
      21,686,000 27,402,000 27,402,000 23,483,000 23,483,000 24,853,000 24,853,000 22,388,000 22,388,000 21,013,000 21,013,000 20,614,000 20,614,000 21,106,000 21,106,000 17,323,000 17,323,000 24,978,000 24,978,000 28,635,000 29,908,000 33,299,000 33,299,000 26,711,000 33,020,000 33,020,000 28,467,000 28,467,000 27,493,000 28,240,000 28,240,000 24,982,000 24,982,000 24,757,000 24,757,000 20,973,000 20,973,000 19,319,000 19,319,000 16,608,000 16,608,000 15,417,000 15,417,000 12,886,000 12,886,000 13,366,000 13,366,000 12,352,000 12,352,000 10,143,000 10,143,000 9,838,000 9,838,000 10,433,000 10,433,000 8,371,000 8,371,000 7,563,000 7,563,000 6,657,000 6,657,000 5,806,000 5,806,000 5,425,000 3,304,000 3,338,000 3,338,000 3,292,000 2,808,000 2,808,000 2,472,000 2,472,000 2,616,000 2,616,000 2,121,000 2,121,000 2,608,000 2,608,000 2,593,000 2,593,000 2,381,000 3,876,000 3,026,000 3,026,000 2,686,000 2,686,000 2,890,000 1,764,000 1,764,000 681,000 681,000 280,000 280,000                                                              
        prepaid expenses and other current assets
      75,596,000 76,595,000 76,595,000 73,829,000 73,829,000 58,696,000 58,696,000 68,478,000 68,478,000 69,838,000 69,838,000 58,247,000 58,247,000 67,490,000 67,490,000 67,926,000 67,926,000 66,891,000 66,891,000 62,259,000 60,654,000 62,211,000 62,211,000 52,903,000 48,281,000 48,281,000 53,333,000 53,333,000 57,530,000 51,564,000 51,564,000 49,878,000 49,878,000 46,341,000 46,341,000 57,011,000 57,011,000 34,470,000 34,470,000 43,937,000 43,937,000 29,773,000 29,773,000 26,988,000 26,988,000 14,490,000 14,490,000 12,847,000 12,847,000 14,146,000 14,146,000 15,017,000 15,017,000 12,279,000 12,279,000 10,327,000 10,327,000 6,850,000 6,850,000 8,750,000 8,750,000 8,012,000 8,012,000 4,433,000 6,297,000 5,416,000 5,416,000 7,148,000 4,657,000 4,657,000 4,791,000 4,791,000 3,806,000 3,806,000 3,949,000 3,949,000 2,731,000 2,731,000 5,212,000 5,212,000 3,481,000 7,860,000 4,792,000 4,792,000 5,386,000 5,386,000 5,112,000 7,799,000 7,799,000 5,880,000 5,880,000 11,030,000 11,030,000 6,104,000 6,104,000 6,098,000 4,498,000 4,498,000 4,641,000 4,641,000 4,372,000 4,372,000 17,062,000 14,555,000 14,555,000 16,766,000 16,766,000 14,926,000 17,635,000 17,635,000 16,025,000 16,025,000 18,000,000 18,000,000 15,050,000 15,050,000 10,621,000 10,621,000 8,882,000 8,882,000 8,453,000 8,453,000 7,713,000 7,713,000 6,760,000 6,760,000 8,201,000 8,201,000 7,689,000 7,689,000 6,151,000 6,151,000 9,755,000 9,755,000 9,478,000 9,478,000 6,997,000 6,997,000 6,082,000 6,082,000 7,502,000 6,152,000 4,951,000 5,442,000    4,350,000       
        total current assets
      1,443,289,000 1,402,257,000 1,402,257,000 1,180,764,000 1,180,764,000 1,396,502,000 1,396,502,000 1,467,579,000 1,467,579,000 1,549,718,000 1,549,718,000 1,477,444,000 1,477,444,000 1,292,429,000 1,292,429,000 1,317,958,000 1,317,958,000 1,443,369,000 1,443,369,000 1,590,527,000 1,637,618,000 1,618,762,000 1,618,762,000 1,841,621,000 1,851,639,000 1,851,639,000 1,842,743,000 1,842,743,000 1,834,747,000 1,662,028,000 1,662,028,000 1,593,246,000 1,593,246,000 1,434,265,000 1,434,265,000 1,445,395,000 1,445,395,000 1,407,808,000 1,407,808,000 1,394,663,000 1,394,663,000 1,136,896,000 1,136,896,000 1,011,190,000 1,011,190,000 972,112,000 972,112,000 957,247,000 957,247,000 946,298,000 946,298,000 897,016,000 897,016,000 786,962,000 786,962,000 686,286,000 686,286,000 565,680,000 565,680,000 484,874,000 484,874,000 470,921,000 470,921,000 402,239,000 467,950,000 470,803,000 470,803,000 421,328,000 353,383,000 353,383,000 339,468,000 339,468,000 178,665,000 178,665,000 207,351,000 207,351,000 91,803,000 91,803,000 125,040,000 125,040,000 167,241,000 220,670,000 258,583,000 258,583,000 298,309,000 298,309,000 266,609,000 306,164,000 306,164,000 374,956,000 374,956,000 383,945,000 383,945,000 432,541,000 432,541,000 493,395,000 213,823,000 213,823,000 250,016,000 250,016,000 228,824,000 228,824,000 244,874,000 283,700,000 283,700,000 324,209,000 324,209,000 183,486,000 192,212,000 192,212,000 234,848,000 234,848,000 177,625,000 177,625,000 230,000,000 230,000,000 306,522,000 306,522,000 213,647,000 213,647,000 230,215,000 230,215,000 271,571,000 271,571,000 117,442,000 117,442,000 173,762,000 173,762,000 245,844,000 245,844,000 283,783,000 283,783,000 294,033,000 294,033,000 240,885,000 240,885,000 289,236,000 289,236,000 262,251,000 262,251,000 142,418,000 188,741,000 218,262,000 210,361,000 214,293,000 197,911,000 141,963,000 163,957,000 142,466,000 170,239,000 209,210,000  207,361,000 234,943,000 
        non-current marketable securities
      603,603,000 578,287,000 578,287,000 594,652,000 594,652,000 619,441,000 619,441,000 637,291,000 637,291,000 523,421,000 523,421,000                                                                                                                                                
        property and equipment
      98,960,000 104,748,000 104,748,000 110,314,000 110,314,000 115,030,000 115,030,000 119,391,000 119,391,000 124,414,000 124,414,000 130,210,000 130,210,000 127,222,000 127,222,000 128,731,000 128,731,000 121,039,000 121,039,000 115,004,000 116,212,000 110,624,000 110,624,000 107,909,000 108,529,000 108,529,000 106,169,000 106,169,000 104,031,000 99,838,000 99,838,000 95,133,000 95,133,000 78,453,000 78,453,000 67,384,000 67,384,000 56,385,000 56,385,000 52,323,000 52,323,000 48,489,000 48,489,000 48,892,000 48,892,000 49,467,000 49,467,000 50,709,000 50,709,000 50,553,000 50,553,000 50,897,000 50,897,000 51,046,000 51,046,000 64,744,000 64,744,000 45,412,000 45,412,000 25,743,000 25,743,000 19,256,000 19,256,000 18,684,000 2,594,000 2,071,000 2,071,000 1,737,000 1,982,000 1,982,000 1,813,000 1,813,000 1,434,000 1,434,000 1,448,000 1,448,000 1,812,000 1,812,000 2,158,000 2,158,000 2,432,000 2,928,000 4,052,000 4,052,000 4,685,000 4,685,000 4,910,000 5,520,000 5,520,000 5,650,000 5,650,000 5,786,000 5,786,000 6,059,000 6,059,000 6,292,000 6,439,000 6,439,000 7,326,000 7,326,000 8,506,000 8,506,000 10,196,000 11,903,000 11,903,000 13,605,000 13,605,000 15,811,000 18,776,000 18,776,000 20,923,000 20,923,000 24,379,000 24,379,000 29,392,000 29,392,000 28,481,000 28,481,000 30,696,000 30,696,000 33,354,000 33,354,000 36,247,000 36,247,000 38,683,000 38,683,000 39,417,000 39,417,000 35,825,000 35,825,000 34,664,000 34,664,000 36,266,000 36,266,000 34,621,000 34,621,000 32,451,000 32,451,000 32,294,000 32,294,000 33,344,000 33,769,000 33,715,000 35,577,000 36,144,000 36,965,000 36,065,000 35,463,000 33,795,000 33,794,000 32,077,000  34,622,000 35,282,000 
        deferred tax assets
      292,582,000 418,582,000 418,582,000 419,241,000 419,241,000 419,045,000 419,045,000 420,027,000 420,027,000 358,869,000 358,869,000 361,561,000 361,561,000 361,578,000 361,578,000 361,145,000 361,145,000 230,990,000 230,990,000 231,115,000 229,603,000 231,110,000 231,110,000 116,415,000 113,958,000 113,958,000 98,001,000 98,001,000 111,663,000 125,295,000 125,295,000 134,667,000 134,667,000 160,598,000 160,598,000 156,711,000 156,711,000 155,678,000 155,678,000 148,235,000 148,235,000 163,187,000 163,187,000 172,374,000 172,374,000 186,836,000 186,836,000 210,237,000 210,237,000 243,717,000 243,717,000 244,111,000 244,111,000                                                                                                      
        goodwill
      63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 63,684,000 65,999,000 65,999,000 67,364,000 67,364,000 67,364,000 67,364,000 67,364,000 67,364,000 67,364,000 67,364,000 67,364,000 67,364,000 67,364,000 67,364,000 67,364,000 67,364,000 67,364,000 67,364,000 67,364,000  67,364,000 67,364,000 
        right-of-use assets and other non-current assets
      342,305,000 255,989,000 255,989,000 309,426,000 309,426,000 223,545,000 223,545,000 239,718,000 239,718,000 340,170,000 340,170,000 307,917,000 307,917,000                                                                                                                                              
        total assets
      2,844,423,000 2,823,547,000 2,823,547,000 2,678,081,000 2,678,081,000 2,837,247,000 2,837,247,000 2,947,690,000 2,947,690,000 2,960,276,000 2,960,276,000 2,773,121,000 2,773,121,000 2,803,752,000 2,803,752,000 2,942,357,000 2,942,357,000 2,976,910,000 2,976,910,000 3,142,468,000 3,143,359,000 3,071,489,000 3,071,489,000 2,961,372,000 2,881,404,000 2,881,404,000 2,654,118,000 2,654,118,000 2,616,239,000 2,447,741,000 2,447,741,000 2,367,271,000 2,367,271,000 2,190,542,000 2,190,542,000 2,137,333,000 2,137,333,000 2,111,043,000 2,111,043,000 2,046,548,000 2,046,548,000 1,955,604,000 1,955,604,000 1,885,670,000 1,885,670,000 1,784,865,000 1,784,865,000 1,643,098,000 1,643,098,000 1,541,794,000 1,541,794,000 1,422,286,000 1,422,286,000 1,024,366,000 1,024,366,000 911,158,000 911,158,000 774,915,000 774,915,000 655,294,000 655,294,000 609,772,000 609,772,000 516,532,000 586,980,000 597,541,000 597,541,000 548,490,000 477,136,000 477,136,000 492,533,000 492,533,000 332,342,000 332,342,000 363,241,000 363,241,000 248,778,000 248,778,000 282,934,000 282,934,000 327,960,000 383,656,000 440,635,000 440,635,000 497,565,000 497,565,000 503,287,000 555,959,000 555,959,000 612,084,000 612,084,000 659,527,000 659,527,000 721,097,000 721,097,000 762,613,000 374,488,000 374,488,000 412,600,000 412,600,000 393,262,000 393,262,000 411,636,000 454,182,000 454,182,000 495,736,000 495,736,000 360,790,000 372,906,000 372,906,000 419,725,000 419,725,000 284,220,000 284,220,000 343,410,000 343,410,000 421,102,000 421,102,000 333,177,000 333,177,000 355,105,000 355,105,000 401,622,000 401,622,000 254,763,000 254,763,000 316,621,000 316,621,000 370,572,000 370,572,000 412,120,000 412,120,000 420,291,000 420,291,000 371,788,000 371,788,000 420,631,000 420,631,000 395,417,000 395,417,000 270,657,000 306,477,000 337,582,000 332,712,000 338,706,000 325,145,000 269,753,000 291,340,000 267,869,000 287,193,000 321,657,000  336,824,000 359,230,000 
        liabilities and stockholders’ equity
                                                                                                                                                                
        current liabilities:
                                                                                                                                                                
        accounts payable
      29,623,000 25,348,000 25,348,000 25,821,000 25,821,000 42,840,000 42,840,000 38,191,000 38,191,000 59,309,000 59,309,000 28,676,000 28,676,000 26,069,000 26,069,000 33,768,000 33,768,000 26,450,000 26,450,000 25,994,000 32,621,000 32,667,000 32,667,000 30,572,000 19,978,000 19,978,000 17,285,000 17,285,000 24,258,000 24,314,000 24,314,000 20,450,000 20,450,000 13,821,000 13,821,000 23,632,000 23,632,000 47,927,000 47,927,000 9,103,000 9,103,000 15,321,000 15,321,000 11,581,000 11,581,000 8,352,000 8,352,000 12,274,000 12,274,000 9,748,000 9,748,000 10,901,000 10,901,000 8,679,000 8,679,000 13,023,000 13,023,000 11,078,000 11,078,000 9,575,000 9,575,000 5,988,000 5,988,000 7,037,000 4,649,000 6,565,000 6,565,000 3,965,000 5,435,000 5,435,000 5,657,000 5,657,000 6,401,000 6,401,000 2,256,000 2,256,000 3,398,000 3,398,000 1,303,000 1,303,000 6,413,000 3,362,000 4,638,000 4,638,000 4,943,000 4,943,000 9,345,000 3,559,000 3,559,000 3,458,000 3,458,000 3,498,000 3,498,000 4,398,000 4,398,000 3,246,000 2,931,000 2,931,000 1,878,000 1,878,000 1,957,000 1,957,000 3,390,000 2,298,000 2,298,000 2,945,000 2,945,000 2,046,000 2,906,000 2,906,000 3,343,000 3,343,000 3,577,000 3,577,000 7,403,000 7,403,000 4,048,000 4,048,000 7,904,000 7,904,000 4,570,000 4,570,000 4,946,000 4,946,000 7,342,000 7,342,000 6,928,000 6,928,000 9,198,000 9,198,000 9,288,000 9,288,000 5,041,000 5,041,000 5,004,000 5,004,000 5,433,000 5,433,000 3,699,000 3,699,000 2,755,000 3,095,000 3,120,000 1,689,000 2,065,000 3,565,000 2,204,000 5,931,000 1,622,000 1,811,000 2,938,000  1,592,000 3,304,000 
        accrued compensation and benefits
      102,218,000 104,364,000 104,364,000 72,250,000 72,250,000 89,747,000 89,747,000 109,830,000 109,830,000 90,605,000 90,605,000 71,806,000 71,806,000 72,958,000 72,958,000 93,325,000 93,325,000 81,398,000 81,398,000 68,213,000 56,551,000 77,158,000 77,158,000 66,927,000 61,450,000 61,450,000 42,768,000 42,768,000 61,969,000 53,306,000 53,306,000 48,324,000 48,324,000 37,945,000 37,945,000 51,189,000 51,189,000 40,782,000 40,782,000 33,156,000 33,156,000 26,687,000 26,687,000 37,364,000 37,364,000 31,713,000 31,713,000 24,144,000 24,144,000 22,550,000 22,550,000 32,142,000 32,142,000 27,283,000 27,283,000 21,538,000 21,538,000 20,756,000 20,756,000 21,073,000 21,073,000 19,914,000 19,914,000 15,555,000 14,490,000 20,334,000 20,334,000 15,986,000 10,307,000 10,307,000 6,042,000 6,042,000 3,629,000 3,629,000 3,725,000 3,725,000 3,249,000 3,249,000 3,459,000 3,459,000 3,350,000 6,441,000 9,856,000 9,856,000 8,088,000 8,088,000 12,797,000 9,342,000 9,342,000 8,127,000 8,127,000 6,500,000 6,500,000 10,375,000 10,375,000 8,255,000 7,914,000 7,914,000 6,586,000 6,586,000 8,943,000 8,943,000 8,835,000 8,159,000 8,159,000 6,888,000 6,888,000 12,078,000 12,069,000 12,069,000 11,459,000 11,459,000 20,500,000 20,500,000 16,677,000 16,677,000 15,215,000 15,215,000 13,910,000 13,910,000 11,383,000 11,383,000 16,142,000 16,142,000 17,828,000 17,828,000 13,093,000 13,093,000 13,303,000 13,303,000 14,480,000 14,480,000 14,610,000 14,610,000 10,580,000 10,580,000 10,880,000 10,880,000 11,456,000 11,456,000 10,781,000 7,004,000 6,791,000 7,817,000 7,236,000 5,449,000 4,950,000 6,297,000 6,330,000 5,049,000 4,914,000  5,743,000 4,379,000 
        accrued clinical trial liabilities
      65,742,000 57,781,000 57,781,000 57,874,000 57,874,000 57,635,000 57,635,000 57,976,000 57,976,000 56,184,000 56,184,000 64,829,000 64,829,000 59,337,000 59,337,000 71,615,000 71,615,000 62,842,000 62,842,000 59,260,000 64,210,000 65,072,000 65,072,000 62,057,000 76,740,000 76,740,000 82,885,000 82,885,000 77,544,000 70,618,000 70,618,000 67,075,000 67,075,000 59,762,000 59,762,000 52,251,000 52,251,000 47,074,000 47,074,000 39,940,000 39,940,000 34,969,000 34,969,000 38,777,000 38,777,000 30,330,000 30,330,000 23,709,000 23,709,000 23,055,000 23,055,000 18,231,000 18,231,000 18,958,000 18,958,000 16,801,000 16,801,000 15,351,000 15,351,000 19,849,000 19,849,000 16,181,000 16,181,000 14,680,000 14,478,000 14,131,000 14,131,000 14,887,000 15,681,000 15,681,000 16,135,000 16,135,000 18,071,000 18,071,000 29,788,000 29,788,000 32,572,000 32,572,000 30,976,000 30,976,000 41,545,000 45,102,000 41,367,000 41,367,000 39,118,000 39,118,000 34,958,000 35,042,000 35,042,000 29,406,000 29,406,000 21,263,000 21,263,000 20,560,000 20,560,000 23,701,000 23,982,000 23,982,000 21,634,000 21,634,000 21,729,000 21,729,000 24,957,000 28,761,000 28,761,000 31,681,000 31,681,000 30,975,000 30,060,000 30,060,000 29,200,000 29,200,000 27,713,000 27,713,000 24,000,000 24,000,000 18,982,000 18,982,000 15,140,000 15,140,000 20,752,000 20,752,000 22,551,000 22,551,000 26,674,000 26,674,000 25,280,000 25,280,000 24,101,000 24,101,000 21,651,000 21,651,000 19,554,000 19,554,000 17,811,000 17,811,000 15,866,000 15,866,000 12,209,000 12,209,000               
        rebates and fees due to customers
      59,896,000 58,234,000 58,234,000 57,276,000 57,276,000 57,840,000 57,840,000 62,376,000 62,376,000 62,495,000 62,495,000 58,468,000 58,468,000 75,651,000 75,651,000 59,619,000 59,619,000 54,374,000 54,374,000 52,486,000 66,405,000 50,350,000 50,350,000 43,791,000 43,795,000 43,795,000 49,997,000 49,997,000 33,700,000 31,120,000 31,120,000 31,197,000 31,197,000 31,468,000 31,468,000 20,683,000 20,683,000 19,129,000 19,129,000 16,957,000 16,957,000 23,006,000 23,006,000 18,719,000 18,719,000 16,782,000 16,782,000 17,273,000 17,273,000 19,708,000 19,708,000 14,954,000 14,954,000 11,689,000 11,689,000 11,143,000 11,143,000 11,989,000 11,989,000 7,565,000 7,565,000                                                                                              
        accrued collaboration liabilities
      22,783,000 23,428,000 23,428,000 21,525,000 21,525,000 25,489,000 25,489,000 40,384,000 40,384,000 30,030,000 30,030,000 18,683,000 18,683,000 34,704,000 34,704,000 27,533,000 27,533,000 27,269,000 27,269,000 22,960,000 18,324,000 20,188,000 20,188,000 18,277,000 29,990,000 29,990,000 32,492,000 32,492,000 86,753,000 35,403,000 35,403,000 24,428,000 24,428,000 13,461,000 13,461,000 12,456,000 12,456,000 11,102,000 11,102,000 10,695,000 10,695,000 8,663,000 8,663,000 11,856,000 11,856,000 7,973,000 7,973,000 7,847,000 7,847,000 7,556,000 7,556,000 7,419,000 7,419,000 8,397,000 8,397,000 7,713,000 7,713,000 7,974,000 7,974,000 8,974,000 8,974,000 9,137,000 9,137,000 7,919,000                                                                                           
        other current liabilities
      125,382,000 104,622,000 104,622,000 101,365,000 101,365,000 125,551,000 125,551,000 95,012,000 95,012,000 95,723,000 95,723,000 103,241,000 103,241,000 104,291,000 104,291,000 108,417,000 108,417,000 124,483,000 124,483,000 110,704,000 89,486,000 78,924,000 78,924,000 80,109,000 72,568,000 72,568,000 63,652,000 63,652,000 53,366,000 54,747,000 54,747,000 63,852,000 63,852,000 56,880,000 56,880,000 44,447,000 44,447,000 35,329,000 35,329,000 32,830,000 32,830,000 31,831,000 31,831,000 24,449,000 24,449,000 45,919,000 45,919,000 25,228,000 25,228,000 40,139,000 40,139,000 21,825,000 21,825,000 15,900,000 15,900,000 23,787,000 23,787,000 17,711,000 17,711,000 16,150,000 16,150,000 26,356,000 26,356,000 21,225,000 24,659,000 20,771,000 20,771,000                                                                                        
        total current liabilities
      405,644,000 373,777,000 373,777,000 336,111,000 336,111,000 399,102,000 399,102,000 403,769,000 403,769,000 394,346,000 394,346,000 345,703,000 345,703,000 373,010,000 373,010,000 394,277,000 394,277,000 376,816,000 376,816,000 339,617,000 327,597,000 324,359,000 324,359,000 301,733,000 304,521,000 304,521,000 289,079,000 289,079,000 337,590,000 269,508,000 269,508,000 255,326,000 255,326,000 213,337,000 213,337,000 204,658,000 204,658,000 201,343,000 201,343,000 142,681,000 142,681,000 140,477,000 140,477,000 142,746,000 142,746,000 141,069,000 141,069,000 110,796,000 110,796,000 125,132,000 125,132,000 105,472,000 105,472,000 90,906,000 90,906,000 99,944,000 99,944,000 84,859,000 84,859,000 115,170,000 115,170,000 108,953,000 108,953,000 97,671,000 202,287,000 270,588,000 270,588,000 201,643,000 192,795,000 192,795,000 101,067,000 101,067,000 52,251,000 52,251,000 55,922,000 55,922,000 60,316,000 60,316,000 58,680,000 58,680,000 171,860,000 173,912,000 171,857,000 171,857,000 71,056,000 71,056,000 87,853,000 77,880,000 77,880,000 74,600,000 74,600,000 67,799,000 67,799,000 81,704,000 81,704,000 85,415,000 90,147,000 90,147,000 87,459,000 87,459,000 92,325,000 92,325,000 166,615,000 193,542,000 193,542,000 198,123,000 198,123,000 199,941,000 203,969,000 203,969,000 222,015,000 222,015,000 210,344,000 210,344,000 207,118,000 207,118,000 214,995,000 214,995,000 184,474,000 184,474,000 176,458,000 176,458,000 189,543,000 189,543,000 118,882,000 118,882,000 134,142,000 134,142,000 132,781,000 132,781,000 132,885,000 132,885,000 120,491,000 120,491,000 115,821,000 115,821,000 125,822,000 125,822,000 111,437,000 111,437,000 82,331,000 86,470,000 124,319,000 108,755,000 88,693,000 91,893,000 67,981,000 63,796,000 42,168,000 40,565,000 47,814,000  44,487,000 50,598,000 
        non-current operating lease liabilities
      173,038,000 176,463,000 176,463,000 179,842,000 179,842,000 187,125,000 187,125,000 190,823,000 190,823,000                                                                                                                                                  
        other non-current liabilities
      104,422,000 112,607,000 112,607,000 128,592,000 128,592,000 119,996,000 119,996,000 108,895,000 108,895,000 96,066,000 96,066,000                                                                                                                                                
        total liabilities
      683,104,000 662,847,000 662,847,000 644,545,000 644,545,000 706,223,000 706,223,000 703,487,000 703,487,000 684,857,000 684,857,000 653,387,000 653,387,000 675,744,000 675,744,000 678,445,000 678,445,000 629,290,000 629,290,000 614,530,000 588,223,000 583,062,000 583,062,000 469,970,000 490,144,000 490,144,000 360,267,000 360,267,000 405,624,000 335,294,000 335,294,000 324,194,000 324,194,000 279,355,000 279,355,000 258,220,000 258,220,000 259,012,000 259,012,000 213,224,000 213,224,000 207,952,000 207,952,000 199,700,000 199,700,000 181,148,000 181,148,000 154,466,000 154,466,000 156,774,000 156,774,000 134,833,000 134,833,000 108,400,000 108,400,000 136,190,000 136,190,000 105,149,000 105,149,000 370,333,000 370,333,000 371,057,000 371,057,000 368,021,000 467,230,000 508,223,000 508,223,000 516,468,000 663,270,000 663,270,000 648,487,000 648,487,000 436,646,000 436,646,000 437,469,000 437,469,000 436,966,000 436,966,000 429,693,000 429,693,000 442,789,000 442,167,000 437,392,000 437,392,000 426,083,000 426,083,000 437,049,000 423,196,000 423,196,000 415,752,000 415,752,000 404,675,000 404,675,000 424,663,000 424,663,000 421,768,000 275,439,000 275,439,000 280,251,000 280,251,000 302,630,000 302,630,000 408,582,000 535,997,000 535,997,000 564,485,000 564,485,000 589,115,000 590,499,000 590,499,000 634,419,000 634,419,000 483,505,000 483,505,000 507,135,000 507,135,000 563,872,000 563,872,000 456,796,000 456,796,000 444,053,000 444,053,000 457,883,000 457,883,000 278,211,000 278,211,000 304,563,000 304,563,000 321,178,000 321,178,000 326,609,000 326,609,000 319,657,000 319,657,000 327,982,000 327,982,000 351,160,000 351,160,000 304,806,000 304,806,000 245,321,000 255,013,000 303,060,000 275,417,000 254,158,000 262,931,000 236,645,000 240,669,000 187,202,000 180,077,000 187,010,000  153,373,000 158,766,000 
        commitments and contingencies
                                                                                                                                                                
        stockholders’ equity:
                                                                                                                                                                
        preferred stock, 0.001 par value...
                                                                                                                                                                
        common stock, 0.001 par value...
      262,000 268,000 268,000 270,000 270,000 275,000 275,000 282,000 282,000 286,000 286,000 285,000 285,000 295,000 295,000 303,000 303,000 311,000 311,000 320,000 325,000 324,000 324,000 323,000 322,000 322,000 320,000 320,000 319,000 316,000 316,000 315,000 315,000 313,000 313,000 312,000 312,000 309,000 309,000 309,000 309,000 306,000 306,000 305,000 305,000 304,000 304,000 303,000 303,000 302,000 302,000 300,000 300,000 299,000 299,000 298,000 298,000 297,000 297,000 296,000 296,000 296,000 296,000 294,000 292,000 290,000 290,000 286,000 230,000 230,000 228,000 228,000 228,000 228,000 225,000 225,000 196,000 196,000 196,000 196,000 196,000 195,000 195,000 195,000 194,000 194,000 184,000 184,000 184,000 184,000 184,000 184,000 184,000 183,000 183,000             109,000       108,000 108,000       106,000 106,000       105,000 105,000       96,000 96,000    84,000    75,000       
        additional paid-in-capital
      2,234,411,000 2,262,928,000 2,262,928,000 2,251,456,000 2,251,456,000 2,292,033,000 2,292,033,000 2,343,915,000 2,343,915,000                                                                                       1,542,489,000 1,267,890,000 1,267,890,000 1,264,659,000 1,264,659,000 1,196,992,000 1,196,992,000 1,155,827,000 1,148,588,000 1,148,588,000 1,140,700,000 1,140,700,000 953,608,000 946,469,000 946,469,000 940,765,000 940,765,000 933,481,000 933,481,000 925,736,000 925,736,000 917,916,000 917,916,000 911,699,000 911,699,000 903,069,000 903,069,000 897,423,000 897,423,000 889,313,000 889,313,000 883,208,000 883,208,000 871,443,000 871,443,000 863,127,000 863,127,000 855,403,000 855,403,000 776,617,000 776,617,000 766,282,000 766,282,000 756,568,000 756,568,000 659,198,000 654,761,000 644,096,000 636,263,000 634,264,000 584,045,000 579,284,000 569,345,000 547,251,000 546,569,000 543,922,000  541,276,000 532,913,000 
        accumulated other comprehensive income
      3,476,000 3,565,000 3,565,000 1,349,000 1,349,000 2,010,000 2,010,000   3,956,000 3,956,000                  -758,000 1,481,000 1,481,000 1,985,000 1,985,000 2,740,000 2,740,000 4,476,000 4,476,000 6,239,000 6,239,000 7,840,000 7,840,000 -222,000 -222,000 3,069,000 3,069,000 2,668,000 2,668,000 2,207,000 2,207,000 728,000 728,000                  129,000 129,000           -121,000 24,000 177,000 177,000 153,000 153,000 146,000 180,000 180,000   102,000 102,000   -18,000 5,000 5,000 50,000 50,000 -138,000 -138,000 -249,000 -13,000 -13,000 -32,000 -32,000 12,000 18,000 18,000 18,000 18,000 99,000 99,000 155,000 155,000 96,000 96,000 20,000 20,000 3,000 3,000   178,000 178,000 602,000 602,000 1,236,000 1,236,000 499,000 499,000 1,017,000 1,017,000 1,102,000 1,102,000 1,080,000 1,080,000 1,145,000 1,145,000 1,207,000 1,028,000 1,007,000 973,000 812,000 844,000 532,000 624,000 794,000 736,000 1,624,000  1,563,000 2,210,000 
        accumulated deficit
      -76,830,000 -106,061,000 -106,061,000 -219,539,000 -219,539,000 -163,294,000 -163,294,000 -98,647,000 -98,647,000 -90,293,000 -90,293,000 -199,972,000 -199,972,000 -258,948,000 -258,948,000 -173,351,000 -173,351,000 -126,049,000 -126,049,000   -34,225,000 -34,225,000 -4,052,000 -77,262,000 -77,262,000 -147,934,000 -147,934,000 -216,507,000 -311,673,000 -311,673,000 -349,877,000 -349,877,000 -445,969,000 -445,969,000 -447,570,000 -447,570,000 -475,958,000 -475,958,000 -443,918,000 -443,918,000 -510,739,000 -510,739,000 -559,351,000 -559,351,000 -628,094,000 -628,094,000 -725,546,000 -725,546,000 -804,588,000 -804,588,000 -880,363,000 -880,363,000 -1,240,452,000 -1,240,452,000 -1,367,316,000 -1,367,316,000 -1,454,810,000 -1,454,810,000 -1,829,172,000 -1,829,172,000 -1,867,661,000 -1,867,661,000 -1,949,043,000 -1,966,699,000 -1,983,147,000 -1,983,147,000 -2,018,270,000 -2,035,403,000 -2,035,403,000 -1,998,388,000 -1,998,388,000 -1,937,041,000 -1,937,041,000 -1,893,400,000 -1,893,400,000 -1,845,836,000 -1,845,836,000 -1,802,474,000 -1,802,474,000 -1,767,304,000 -1,709,351,000 -1,646,791,000 -1,646,791,000 -1,573,381,000 -1,573,381,000 -1,498,762,000 -1,428,016,000 -1,428,016,000 -1,360,892,000 -1,360,892,000 -1,298,731,000 -1,298,731,000 -1,254,002,000 -1,254,002,000 -1,201,809,000 -1,168,995,000 -1,168,995,000 -1,132,508,000 -1,132,508,000 -1,106,357,000 -1,106,357,000 -1,152,653,000 -1,230,518,000 -1,230,518,000 -1,209,544,000 -1,209,544,000 -1,182,054,000 -1,164,189,000 -1,164,189,000 -1,155,586,000 -1,155,586,000 -1,132,973,000 -1,132,973,000 -1,089,724,000 -1,089,724,000 -1,060,889,000 -1,060,889,000 -1,035,445,000 -1,035,445,000 -990,684,000 -990,684,000 -954,504,000 -954,504,000 -916,555,000 -916,555,000 -878,048,000 -878,048,000 -832,924,000 -832,924,000 -791,650,000 -791,650,000 -771,728,000 -771,728,000 -758,032,000 -758,032,000 -729,470,000 -729,470,000 -705,269,000 -705,269,000 -680,087,000 -654,890,000 -630,900,000 -603,777,000 -579,255,000 -556,481,000 -546,784,000 -519,373,000       
        total stockholders’ equity
      2,161,319,000 2,160,700,000 2,160,700,000 2,033,536,000 2,033,536,000 2,131,024,000 2,131,024,000 2,244,203,000 2,244,203,000 2,275,419,000 2,275,419,000 2,119,734,000 2,119,734,000 2,128,008,000 2,128,008,000 2,263,912,000 2,263,912,000 2,347,620,000 2,347,620,000   2,488,427,000 2,488,427,000      2,210,615,000 2,112,447,000 2,112,447,000 2,043,077,000 2,043,077,000 1,911,187,000 1,911,187,000 1,879,113,000 1,879,113,000 1,852,031,000 1,852,031,000 1,833,324,000 1,833,324,000 1,747,652,000 1,747,652,000 1,685,970,000 1,685,970,000 1,603,717,000 1,603,717,000 1,488,632,000 1,488,632,000 1,385,020,000 1,385,020,000 1,287,453,000 1,287,453,000 915,966,000 915,966,000 774,968,000 774,968,000 669,766,000 669,766,000 284,961,000 284,961,000 238,715,000 238,715,000 148,511,000 119,750,000 89,318,000 89,318,000 32,022,000               3,243,000 3,243,000 71,482,000 71,482,000 66,238,000 132,763,000 132,763,000 196,332,000 196,332,000 254,852,000 254,852,000 296,434,000 296,434,000 340,845,000 99,049,000 99,049,000 132,349,000 132,349,000 90,632,000 90,632,000 3,054,000                    -56,975,000 -56,975,000 -26,958,000 -26,958,000 5,867,000 5,867,000 39,860,000 39,860,000 72,081,000 72,081,000 84,796,000 84,796,000 19,784,000 19,784,000 37,989,000 37,989,000 52,540,000 52,540,000 -19,598,000 984,000 14,288,000 33,543,000 55,905,000 28,485,000 33,108,000 50,671,000 80,667,000 107,116,000 134,647,000  183,451,000 200,464,000 
        total liabilities and stockholders’ equity
      2,844,423,000 2,823,547,000 2,823,547,000 2,678,081,000 2,678,081,000 2,837,247,000 2,837,247,000 2,947,690,000 2,947,690,000       2,942,357,000 2,942,357,000     3,071,489,000 3,071,489,000      2,616,239,000 2,447,741,000 2,447,741,000 2,367,271,000 2,367,271,000 2,190,542,000 2,190,542,000 2,137,333,000 2,137,333,000 2,111,043,000 2,111,043,000 2,046,548,000 2,046,548,000 1,955,604,000 1,955,604,000 1,885,670,000 1,885,670,000 1,784,865,000 1,784,865,000 1,643,098,000 1,643,098,000 1,541,794,000 1,541,794,000 1,422,286,000 1,422,286,000 1,024,366,000 1,024,366,000 911,158,000 911,158,000 774,915,000 774,915,000 655,294,000 655,294,000 609,772,000 609,772,000 516,532,000 586,980,000 597,541,000 597,541,000 548,490,000               440,635,000 440,635,000 497,565,000 497,565,000 503,287,000 555,959,000 555,959,000 612,084,000 612,084,000 659,527,000 659,527,000 721,097,000 721,097,000 762,613,000 374,488,000 374,488,000 412,600,000 412,600,000 393,262,000 393,262,000 411,636,000                                          338,706,000 325,145,000 269,753,000 291,340,000 267,869,000 287,193,000 321,657,000  336,824,000 359,230,000 
        accumulated other comprehensive loss
             -1,347,000 -1,347,000   -5,149,000 -5,149,000 -5,204,000 -5,204,000 -3,750,000 -3,750,000 -14,012,000 -14,012,000 -14,437,000 -9,289,000 -14,521,000 -14,521,000 -17,538,000 -8,917,000 -8,917,000 -6,665,000 -6,665,000                        -701,000 -701,000 -513,000 -513,000 -731,000 -731,000 -887,000 -887,000 -347,000 -347,000 -52,000 -52,000 -119,000 -326,000 -416,000 -416,000 -80,000   -42,000 -42,000 -232,000 -232,000 -41,000 -41,000 -174,000 -174,000 -61,000 -61,000          -263,000 -263,000   -92,000 -92,000                                                            
        non-current portion of operating lease liabilities
               194,445,000 194,445,000                                                                                                                                                
        stockholders' equity:
                                                                                                                                                                
        additional paid-in capital
               2,361,470,000 2,361,470,000 2,324,570,000 2,324,570,000 2,391,865,000 2,391,865,000 2,440,710,000 2,440,710,000 2,487,370,000 2,487,370,000 2,530,869,000 2,558,297,000 2,536,849,000 2,536,849,000 2,512,669,000 2,477,117,000 2,477,117,000 2,448,130,000 2,448,130,000 2,427,561,000 2,422,323,000 2,422,323,000 2,390,654,000 2,390,654,000 2,354,103,000 2,354,103,000 2,321,895,000 2,321,895,000 2,321,441,000 2,321,441,000 2,269,093,000 2,269,093,000 2,258,307,000 2,258,307,000 2,241,947,000 2,241,947,000 2,228,839,000 2,228,839,000 2,211,668,000 2,211,668,000 2,188,578,000 2,188,578,000 2,168,217,000 2,168,217,000 2,156,632,000 2,156,632,000 2,142,717,000 2,142,717,000 2,125,166,000 2,125,166,000 2,114,184,000 2,114,184,000 2,106,132,000 2,106,132,000 2,097,379,000 2,086,483,000 2,072,591,000 2,072,591,000 2,050,086,000 1,848,910,000 1,848,910,000 1,842,248,000 1,842,248,000 1,832,741,000 1,832,741,000 1,818,988,000 1,818,988,000 1,657,626,000 1,657,626,000 1,655,580,000 1,655,580,000 1,652,400,000 1,650,621,000 1,649,662,000 1,649,662,000 1,644,516,000 1,644,516,000 1,564,670,000 1,560,415,000 1,560,415,000 1,557,303,000 1,557,303,000 1,553,297,000 1,553,297,000 1,550,345,000 1,550,345,000                                                            
        total liabilities and stockholders' equity
               2,960,276,000 2,960,276,000 2,773,121,000 2,773,121,000 2,803,752,000 2,803,752,000   2,976,910,000 2,976,910,000 3,142,468,000 3,143,359,000   2,961,372,000 2,881,404,000 2,881,404,000 2,654,118,000 2,654,118,000                                                                                                                               
        short-term investments
                 803,540,000 803,540,000 703,695,000 703,695,000 732,308,000 732,308,000 706,528,000 706,528,000 802,335,000 772,536,000 807,273,000 807,273,000 871,706,000 907,938,000 907,938,000 847,060,000 847,060,000 819,905,000 835,406,000 835,406,000 854,171,000 854,171,000 815,285,000 815,285,000 887,319,000 887,319,000 853,835,000 853,835,000 685,895,000 685,895,000 597,028,000 597,028,000 585,742,000 585,742,000 518,350,000 518,350,000 452,328,000 452,328,000 425,713,000 425,713,000 378,559,000 378,559,000 281,000,000 281,000,000 251,516,000 251,516,000 194,589,000 194,589,000 204,607,000 204,607,000 217,741,000 217,741,000 214,044,000 241,094,000 268,117,000 268,117,000 208,462,000 198,292,000 198,292,000 45,235,000 45,235,000 25,426,000 25,426,000 52,169,000 52,169,000 14,648,000 14,648,000 22,258,000 22,258,000 63,890,000 91,937,000 86,177,000 86,177,000 116,033,000 116,033,000 138,475,000 187,203,000 187,203,000 220,198,000 220,198,000 185,332,000 185,332,000 241,371,000 241,371,000                                                  72,929,000 42,682,000 62,189,000 77,078,000 82,851,000 123,722,000 121,551,000  144,627,000 156,774,000 
        long-term investments
                 432,305,000 432,305,000 629,561,000 629,561,000 728,717,000 728,717,000 811,680,000 811,680,000 838,615,000 806,615,000 756,731,000 756,731,000 551,735,000 463,889,000 463,889,000 404,535,000 404,535,000 371,112,000 362,218,000 362,218,000 345,613,000 345,613,000 328,860,000 328,860,000 332,306,000 332,306,000 358,079,000 358,079,000 327,141,000 327,141,000 486,036,000 486,036,000 536,385,000 536,385,000 486,763,000 486,763,000 337,785,000 337,785,000 218,619,000 218,619,000 157,187,000 157,187,000 114,093,000 114,093,000 94,396,000 94,396,000 96,710,000 96,710,000 64,255,000 64,255,000 50,569,000 50,569,000 26,413,000 47,351,000 55,601,000 55,601,000 55,817,000 51,727,000 51,727,000 82,850,000 82,850,000 83,600,000 83,600,000 81,600,000 81,600,000 81,598,000 81,598,000 81,597,000 81,597,000 81,579,000 84,589,000 95,513,000 95,513,000 111,155,000 111,155,000 144,299,000 157,402,000 157,402,000 138,125,000 138,125,000 176,088,000 176,088,000 182,311,000 182,311,000 162,173,000 83,678,000 83,678,000 84,470,000 84,470,000 85,260,000 85,260,000 85,787,000 86,574,000 86,574,000 85,825,000 85,825,000 87,314,000 87,295,000 87,295,000 89,422,000 89,422,000 9,502,000 9,502,000 11,463,000 11,463,000       17,769,000 17,769,000                               
        long-term portion of operating lease liabilities
                 198,017,000 198,017,000 201,466,000 201,466,000 189,944,000 189,944,000 190,858,000 190,858,000 194,694,000 186,948,000 190,170,000 190,170,000 159,838,000 161,019,000 161,019,000 50,636,000 50,636,000 51,272,000 52,252,000 52,252,000 53,223,000 53,223,000 52,837,000 52,837,000 49,086,000 49,086,000 47,626,000 47,626,000 48,334,000 48,334,000 47,883,000 47,883,000 48,011,000 48,011,000                                                                                                              
        other long-term liabilities
                 109,667,000 109,667,000 101,268,000 101,268,000 94,224,000 94,224,000 61,616,000 61,616,000 73,495,000 67,379,000 61,951,000 61,951,000 1,908,000 17,395,000 17,395,000 12,517,000 12,517,000 8,023,000 4,090,000 4,090,000 7,068,000 7,068,000 3,421,000 3,421,000 721,000 721,000 721,000 721,000 7,206,000 7,206,000 5,459,000 5,459,000 2,347,000 2,347,000 975,000 975,000 4,495,000 4,495,000 3,361,000 3,361,000 1,286,000 1,286,000 2,607,000 2,607,000 3,630,000 3,630,000 17,113,000 17,113,000 16,643,000 16,643,000 16,012,000 16,012,000 16,687,000 3,707,000 541,000 541,000 759,000 1,082,000 1,082,000 1,317,000 1,317,000 1,575,000 1,575,000 1,881,000 1,881,000 2,345,000 2,345,000 2,961,000 2,961,000 4,169,000 4,772,000 5,102,000 5,102,000 5,467,000 5,467,000 4,674,000 5,726,000 5,726,000 5,882,000 5,882,000 6,113,000 6,113,000 6,256,000 6,256,000 7,768,000 7,558,000 7,558,000 7,755,000 7,755,000 7,844,000 7,844,000 8,247,000 8,445,000 8,445,000 8,772,000 8,772,000 15,992,000 23,415,000 23,415,000 23,606,000 23,606,000 17,173,000 17,173,000 17,325,000 17,325,000 23,907,000 23,907,000 23,505,000 23,505,000 23,103,000 23,103,000 22,620,000 22,620,000 27,338,000 27,338,000 26,254,000 26,254,000 25,755,000 25,755,000 24,924,000 24,924,000 24,419,000 24,419,000 23,255,000 23,255,000 21,588,000 21,588,000 20,491,000 20,491,000 19,180,000 17,855,000 16,184,000 14,475,000 12,750,000 10,949,000 9,788,000 7,995,000 6,838,000 2,515,000 1,734,000  869,000 619,000 
        right-of-use assets and other
                   329,278,000 329,278,000 342,122,000 342,122,000 306,148,000 306,148,000 303,523,000 289,627,000 290,578,000 290,578,000                                                                                                                                    
        long-term portion of deferred revenues
                         6,724,000    6,491,000 7,209,000 7,209,000 8,035,000 8,035,000  9,444,000 9,444,000 8,577,000 8,577,000 9,760,000 9,760,000   9,322,000 9,322,000 15,003,000 15,003,000                                                                                                                  
        retained earnings
                         11,186,000 5,803,000                                                                                                                                      
        total stockholders' equity
                         2,527,938,000 2,555,136,000   2,491,402,000 2,391,260,000 2,391,260,000 2,293,851,000 2,293,851,000                                                                                                                               
        long-term portion of deferred revenue
                          6,299,000 6,582,000 6,582,000      8,739,000       3,755,000 3,755,000     14,133,000 14,133,000 6,596,000 6,596,000 15,399,000 15,399,000 16,632,000 16,632,000 8,323,000 8,323,000 15,897,000 15,897,000 2,268,000 2,268,000 11,970,000 11,970,000 3,177,000 3,177,000 238,520,000 238,520,000 246,092,000 246,092,000 253,663,000 261,236,000 237,094,000 237,094,000 232,573,000 180,838,000 180,838,000 184,431,000 184,431,000                                                                                   
        other long-term assets
                             280,008,000 279,705,000 279,705,000 138,986,000 138,986,000 131,002,000 134,678,000 134,678,000 134,928,000 134,928,000 124,682,000 124,682,000 71,853,000 71,853,000 69,409,000 69,409,000 60,502,000 60,502,000 57,312,000 57,312,000 53,145,000 53,145,000 7,268,000 7,268,000 5,763,000 5,763,000 3,902,000 3,902,000 2,424,000 2,424,000 1,492,000 1,492,000 948,000 948,000 1,929,000 1,929,000 12,092,000 12,092,000 692,000 692,000 862,000 1,251,000 1,232,000 1,232,000 1,774,000 2,210,000 2,210,000 2,068,000 2,068,000 2,309,000 2,309,000                                                                                 
        stockholders' equity
                                                                                                                                                                
        commitments
                                                                                                                                                                
        other receivables
                                                   13,801,000 13,801,000 12,390,000 12,390,000 7,445,000 7,445,000 16,056,000 16,056,000                                         2,751,000 2,751,000 2,708,000 2,284,000 2,284,000 1,930,000 1,930,000 30,190,000 30,190,000 4,654,000 6,363,000 6,363,000 5,771,000 5,771,000 5,896,000 7,306,000 7,306,000 6,028,000 6,028,000 7,090,000 7,090,000 11,864,000 11,864,000 9,594,000 9,594,000 8,860,000 8,860,000 3,712,000 3,712,000 1,457,000 1,457,000 1,820,000 1,820,000 6,504,000 6,504,000 9,190,000 9,190,000 6,087,000 6,087,000 8,256,000 8,256,000 2,855,000 2,855,000 3,812,000 3,812,000 22,197,000 22,197,000 3,511,000 1,391,000 5,936,000 7,102,000 6,671,000 4,512,000 13,142,000 4,424,000 5,090,000 2,477,000 3,556,000  2,844,000 4,145,000 
        long-term restricted cash and investments
                                                   1,000,000 1,000,000 1,100,000 1,100,000 1,100,000 1,100,000 1,100,000 1,100,000 1,100,000 1,100,000 1,100,000 1,100,000 1,500,000 1,500,000 4,646,000 4,646,000 4,650,000 4,650,000 4,650,000 4,150,000 4,150,000 4,150,000 4,150,000 4,150,000 4,150,000 2,650,000 2,650,000 2,650,000 2,650,000 2,650,000 2,650,000 2,684,000 2,684,000 2,684,000 2,684,000 4,684,000 4,684,000 10,781,000 10,781,000 10,814,000 10,814,000 16,897,000 15,889,000 15,889,000 21,956,000 21,956,000 21,899,000 21,899,000 27,964,000 27,964,000                                                            
        operating lease right-of-use assets
                                                   17,735,000 17,735,000 16,573,000 16,573,000 13,921,000 13,921,000 5,867,000 5,867,000 5,989,000 5,989,000                                                                                                    
        long-term portion of lease liabilities
                                                   23,705,000 23,705,000 22,543,000 22,543,000 19,958,000 19,958,000 12,178,000 12,178,000 12,619,000 12,619,000                                                                                                    
        current portion of deferred revenue
                                                     321,000 321,000 2,376,000 2,376,000     5,939,000 5,939,000   31,984,000 31,984,000 31,377,000 31,377,000 31,255,000 30,662,000 19,665,000 19,665,000 18,939,000 14,631,000 14,631,000 14,371,000 14,371,000                                                                                   
        unbilled collaboration revenue
                                                       7,244,000 7,244,000   24,489,000 24,489,000   31,844,000 31,844,000                                                                                                
        short-term restricted cash and investments
                                                           504,000 504,000 504,000 504,000 504,000 504,000 504,000 504,000                6,109,000 6,109,000 6,108,000 6,108,000 12,212,000 12,210,000 12,214,000 12,214,000 12,208,000 12,208,000 12,213,000 12,211,000 12,211,000 12,214,000 12,214,000 12,206,000 12,206,000 12,246,000 12,246,000 12,242,000                                                           
        trade and other receivables
                                                           104,634,000 104,634,000 167,161,000 167,161,000 91,999,000 91,999,000 81,192,000 81,192,000 90,005,000 90,005,000 43,125,000 34,076,000 42,246,000 42,246,000 91,207,000 17,799,000 17,799,000 10,088,000 10,088,000 5,183,000 5,183,000 3,470,000 3,470,000 3,758,000 3,758,000 3,882,000 3,882,000 4,882,000 4,722,000 5,034,000 5,034,000 4,457,000 4,457,000 3,941,000 5,171,000 5,171,000 4,209,000 4,209,000 3,865,000 3,865,000                                                              
        financing obligation for build-to-suit lease
                                                             20,646,000 20,646,000                                                                                                  
        convertible notes
                                                                      113,349,000                                                                                          
        term loan payable
                                                                            80,000,000 80,000,000                                                                                   
        stockholders’ equity
                                                                                                                                                                
        accrued collaboration liability
                                                                         18,710,000 16,993,000 16,993,000 14,674,000 14,674,000 10,938,000 10,938,000                                                                                 
        current portion of convertible notes
                                                                       109,122,000 109,122,000 29,365,000 27,500,000 27,500,000 27,500,000 27,500,000   450,000 450,000   3,911,000 3,911,000 98,880,000 96,496,000 94,207,000 94,207,000   10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000                                                            
        current portion of term loan payable
                                                                       80,000,000 80,000,000 80,000,000 80,000,000 80,000,000                                                                                     
        long-term portion of convertible notes
                                                                         81,493,000 288,555,000 288,555,000 281,156,000 281,156,000 301,435,000 301,435,000 297,436,000 297,436,000 291,225,000 291,225,000 284,355,000 284,355,000 182,395,000 177,962,000 173,635,000 173,635,000 261,408,000 261,408,000 255,147,000 248,707,000 248,707,000 242,459,000 242,459,000 236,385,000 236,385,000 240,476,000 240,476,000                                                            
        long-term portion of term loan payable
                                                                                                                                                                
        liabilities and stockholders’ deficit
                                                                                                                                                                
        other accrued liabilities
                                                                         19,791,000 22,248,000 22,248,000 13,671,000 13,671,000 10,007,000 10,007,000 15,969,000 15,969,000 15,803,000 15,803,000 13,867,000 13,867,000 12,282,000 13,855,000 15,859,000 15,859,000 11,974,000 11,974,000 13,116,000 13,017,000 13,017,000 15,362,000 15,362,000 10,392,000 10,392,000 11,795,000 11,795,000 8,882,000 6,425,000 6,425,000 8,218,000 8,218,000 8,423,000 8,423,000 15,195,000 15,569,000 15,569,000 15,993,000 15,993,000 16,797,000 19,625,000 19,625,000 20,243,000 20,243,000 18,837,000 18,837,000 16,399,000 16,399,000 18,742,000 18,742,000 15,467,000 15,467,000 13,915,000 13,915,000 14,007,000 14,007,000       7,594,000 7,594,000 11,499,000 11,499,000 9,657,000 9,657,000   7,018,000 7,018,000               
        preferred stock
                                                                                                                                                                
        stockholders’ deficit:
                                                                                                                                                                
        total stockholders’ deficit
                                                                          -186,134,000 -186,134,000 -155,954,000 -155,954,000 -104,304,000 -104,304,000 -74,228,000 -74,228,000 -188,188,000 -188,188,000 -146,759,000 -146,759,000                        -81,815,000 -81,815,000 -68,749,000 -68,749,000 -228,325,000 -217,593,000 -217,593,000 -214,694,000 -214,694,000 -199,285,000 -199,285,000 -163,725,000 -163,725,000 -142,770,000 -142,770,000 -123,619,000 -123,619,000 -88,948,000 -88,948,000                                 
        total liabilities and stockholders’ deficit
                                                                          477,136,000 477,136,000 492,533,000 492,533,000 332,342,000 332,342,000 363,241,000 363,241,000 248,778,000 248,778,000 282,934,000 282,934,000                        454,182,000 454,182,000 495,736,000 495,736,000 360,790,000   419,725,000 419,725,000 284,220,000 284,220,000 343,410,000 343,410,000 421,102,000 421,102,000 333,177,000 333,177,000 355,105,000 355,105,000                                 
        current portion of restructuring
                                                                            3,017,000 3,017,000 3,205,000 3,205,000 3,734,000 3,734,000 5,294,000 5,294,000 4,993,000 4,993,000 6,426,000 6,580,000 3,726,000 3,726,000 4,298,000 4,298,000 4,425,000 3,776,000 3,776,000 4,194,000 4,194,000 4,077,000 4,077,000 5,085,000 5,085,000 4,033,000 4,484,000 4,484,000 3,875,000 3,875,000 4,483,000 4,483,000 2,725,000 2,624,000 2,624,000 3,850,000 3,850,000                                                
        long-term portion of restructuring
                                                                            516,000 516,000 1,385,000 1,385,000 2,230,000 2,230,000 3,080,000 3,080,000 3,697,000 3,697,000 4,365,000 5,521,000 6,743,000 6,743,000 7,933,000 7,933,000 9,047,000 10,126,000 10,126,000 11,679,000 11,679,000 12,767,000 12,767,000 14,137,000 14,137,000 6,456,000 7,499,000 7,499,000 8,481,000 8,481,000 9,495,000 9,495,000 7,670,000 7,478,000 7,478,000 8,954,000 8,954,000                                                
        current portion of loans payable
                                                                                    164,000 164,000 381,000 757,000 1,077,000 1,077,000 1,392,000 1,392,000 1,762,000 2,127,000 2,127,000 2,546,000 2,546,000 2,858,000 2,858,000 3,170,000 3,170,000                                                            
        deferred revenue
                                                                                    7,000 7,000 2,583,000 1,319,000 1,127,000 1,127,000 1,243,000 1,243,000 1,450,000 1,017,000 1,017,000 1,507,000 1,507,000 9,211,000 9,211,000 16,321,000 16,321,000 24,134,000 31,253,000 31,253,000 31,253,000 31,253,000 41,920,000 41,920,000 76,639,000 99,603,000 99,603,000 99,802,000 99,802,000 100,297,000 102,254,000 102,254,000 119,948,000 119,948,000 101,748,000 101,748,000 103,385,000 103,385,000 118,499,000 118,499,000 91,314,000 91,314,000 83,869,000 83,869,000 88,936,000 88,936,000 45,266,000 45,266,000 63,768,000 63,768,000 65,675,000 65,675,000 64,105,000 64,105,000 57,260,000 57,260,000 60,141,000 60,141,000 72,995,000 72,995,000 63,476,000 63,476,000 43,655,000 51,826,000 59,259,000 43,484,000 27,935,000 32,497,000 41,994,000 28,697,000 15,777,000 15,251,000 20,029,000  17,267,000 24,184,000 
        long-term portion of loans payable
                                                                              80,000,000 80,000,000 80,000,000 80,000,000 80,000,000 80,000,000 80,000,000 80,000,000 80,000,000 80,000,000 80,055,000 80,055,000 80,219,000 80,219,000 80,328,000 80,757,000 80,757,000 81,132,000 81,132,000 81,611,000 81,611,000 82,090,000 82,090,000                                                            
        other assets
                                                                                6,508,000 6,508,000 7,197,000 7,197,000 7,771,000 7,771,000 8,340,000 7,101,000 8,022,000 8,022,000 8,918,000 8,918,000 6,888,000 7,300,000 7,300,000 7,713,000 7,713,000 8,125,000 8,125,000 8,538,000 8,538,000 9,123,000 2,797,000 2,797,000 2,905,000 2,905,000 2,789,000 2,789,000 2,896,000 4,122,000 4,122,000 4,214,000 4,214,000 4,096,000 4,540,000 4,540,000 4,449,000 4,449,000 2,586,000 2,586,000 2,427,000 2,427,000 7,695,000 7,695,000 8,000,000 8,000,000 8,168,000 8,168,000 8,336,000 8,336,000 8,666,000 8,666,000 8,970,000 8,970,000 1,947,000 1,947,000 2,004,000 2,004,000 2,071,000 2,071,000 2,003,000 2,003,000 1,586,000 1,586,000 1,695,000 1,695,000 1,838,000 2,685,000 2,964,000 3,303,000 3,679,000 4,175,000 4,617,000 3,953,000 4,164,000 4,304,000 3,900,000  3,753,000 3,984,000 
        liabilities and stockholders’ (deficit) equity
                                                                                                                                                                
        stockholders’ (deficit) equity:
                                                                                                                                                                
        total stockholders’ (deficit) equity
                                                                                      -114,829,000 -58,511,000                                                                         
        total liabilities and stockholders’ (deficit) equity
                                                                                      327,960,000 383,656,000                                                                         
        *
                                                                                                                                                                
        contingencies
                                                                                                                                                                
        restricted cash and investments
                                                                                                     27,946,000 4,067,000 4,067,000 4,199,000 4,199,000 4,199,000 4,199,000 4,199,000 4,199,000 4,199,000 4,199,000 4,199,000 6,399,000 6,399,000 6,399,000 6,399,000 6,399,000 6,444,000 6,444,000 6,444,000 6,444,000 4,744,000 4,744,000 4,744,000 4,744,000 4,853,000 4,853,000 4,015,000 4,015,000 4,854,000 4,854,000 5,694,000 5,694,000 5,333,000 5,333,000 7,238,000 7,238,000 8,078,000 8,078,000 8,917,000 8,917,000 9,908,000 9,908,000 9,635,000 9,635,000 11,221,000 11,004,000 12,123,000 12,682,000 13,522,000 14,753,000 15,480,000 16,040,000 16,390,000 7,635,000 5,137,000    
        current portion of notes payable and bank obligations
                                                                                                     3,164,000 3,158,000 3,158,000 4,015,000 4,015,000 4,870,000 4,870,000 5,974,000 7,628,000 7,628,000 8,064,000 8,064,000 8,848,000 9,005,000 9,005,000 9,772,000 9,772,000 9,919,000 9,919,000 11,204,000 11,204,000 11,459,000 11,459,000 12,689,000 12,689,000 13,919,000 13,919,000 14,911,000 14,911,000 16,945,000 16,945,000 17,770,000 17,770,000 14,942,000 14,942,000 15,767,000 15,767,000 12,527,000 12,527,000 12,628,000 12,628,000 13,521,000 13,521,000 13,579,000 13,579,000 11,527,000 11,544,000 12,081,000 11,893,000 9,691,000 9,162,000 8,016,000 8,928,000 7,177,000 5,405,000 4,658,000  4,658,000 3,174,000 
        current portion of convertible loans
                                                                                                     10,000,000 10,000,000 10,000,000 10,000,000 10,000,000   28,900,000 28,900,000 28,900,000 28,900,000 28,900,000 28,900,000 28,050,000 28,050,000 28,050,000 28,050,000 28,050,000 28,050,000 28,050,000 28,050,000 28,050,000 28,050,000 28,050,000 28,050,000 28,050,000 28,050,000 28,050,000 28,050,000                               
        long-term portion of notes payable and bank obligations
                                                                                                     82,885,000 83,678,000 83,678,000 84,470,000 84,470,000 85,260,000 85,260,000 85,787,000 86,574,000 86,574,000 85,825,000 85,825,000                                                
        long-term portion of convertible loans
                                                                                                     239,244,000 85,862,000 85,862,000 83,578,000 83,578,000 91,385,000 91,385,000 89,295,000 87,288,000 87,288,000 85,240,000 85,240,000                                                
        183,489,026 and 135,563,735 shares at september 30, 2012 and december 31, 2011, respectively:
                                                                                                     183,000                                                           
        148,794,245 and 135,563,735 shares at june 30, 2012 and december 31, 2011, respectively:
                                                                                                      149,000 149,000                                                         
        148,457,650 and 135,563,735 shares at march 31, 2012 and december 31, 2011, respectively:
                                                                                                        148,000 148,000                                                       
        135,563,735 and 109,287,160 shares at december 31, 2011 and 2010, respectively
                                                                                                          135,000 135,000                                                     
        common stock
                                                                                                            129,000 128,000 128,000 127,000 127,000  109,000 109,000 109,000 109,000 108,000 108,000   107,000 107,000 107,000 107,000 106,000 106,000   106,000 106,000 105,000 105,000 105,000 105,000   104,000 104,000 97,000 97,000 97,000 97,000   84,000 85,000 85,000  84,000 77,000 76,000  73,000 73,000 72,000  72,000 71,000 
        notes payable and bank obligations
                                                                                                                 87,314,000   89,422,000 89,422,000 9,502,000 9,502,000 11,463,000 11,463,000 9,976,000 9,976,000 12,406,000 12,406,000 14,831,000 14,831,000 17,769,000 17,769,000 21,433,000 21,433,000 25,094,000 25,094,000 17,939,000 17,939,000 20,747,000 20,747,000 14,841,000 14,841,000 17,713,000 17,713,000 20,633,000 20,633,000 23,074,000 23,074,000 15,965,000 18,301,000 21,250,000 21,858,000 19,672,000 22,380,000 18,633,000 21,398,000 17,791,000 13,271,000 13,273,000  11,834,000 8,297,000 
        convertible loans
                                                                                                                 83,396,000   108,900,000 108,900,000 28,900,000 28,900,000 28,900,000 28,900,000 56,950,000 56,950,000 56,950,000 56,950,000 56,950,000 56,950,000 56,950,000 56,950,000 85,000,000 85,000,000 85,000,000 85,000,000 85,000,000 85,000,000 85,000,000 85,000,000 85,000,000 85,000,000 85,000,000 85,000,000 85,000,000 85,000,000 85,000,000 85,000,000               
        liabilities, noncontrolling interest and stockholders’ deficit
                                                                                                                                                                
        long term portion of notes payable and bank obligations
                                                                                                                  87,295,000 87,295,000                                             
        long term portion of convertible loans
                                                                                                                  110,561,000 110,561,000                                             
        exelixis, inc. stockholders’ deficit:
                                                                                                                                                                
        total exelixis, inc. stockholders’ deficit
                                                                                                                  -217,593,000 -217,593,000 -214,694,000 -214,694,000 -199,285,000 -199,285,000 -163,725,000 -163,725,000 -142,770,000 -142,770,000 -123,619,000 -123,619,000 -87,506,000 -87,506,000                                 
        noncontrolling interest
                                                                                                                              -1,442,000 -1,442,000                                 
        total liabilities, noncontrolling interest, and stockholders’ deficit
                                                                                                                  372,906,000 372,906,000                                             
        liabilities, noncontrolling interest and stockholders’ equity
                                                                                                                                                                
        investments held by symphony evolution, inc.
                                                                                                                              12,581,000 12,581,000 14,703,000 14,703,000 18,473,000 18,473,000 22,376,000 22,376,000 27,573,000 27,573,000 30,935,000 30,935,000 38,731,000 38,731,000 44,709,000 44,709,000 50,952,000 50,952,000 55,087,000 55,087,000 59,740,000 65,036,000 30,279,000 34,039,000 37,542,000 40,005,000         
        long-term marketable securities
                                                                                                                          9,976,000 9,976,000 12,406,000 12,406,000 14,831,000 14,831,000   21,434,000 21,434,000 25,094,000 25,094,000 17,939,000 17,939,000 20,747,000 20,747,000 13,516,000 13,516,000 15,537,000 15,537,000 17,553,000 17,553,000 19,573,000 19,573,000 11,768,000              
        noncontrolling interest in symphony evolution, inc.
                                                                                                                                714,000 714,000 3,510,000 3,510,000 6,191,000 6,191,000 9,534,000 9,534,000 13,430,000 13,430,000 15,838,000 15,838,000 24,022,000 24,022,000 31,482,000 31,482,000 38,071,000 38,071,000 44,934,000 50,480,000 20,234,000 23,752,000 28,643,000 33,729,000         
        total liabilities, noncontrolling interest and stockholders’ equity
                                                                                                                                401,622,000 401,622,000 254,763,000 254,763,000 316,621,000 316,621,000 370,572,000 370,572,000 412,120,000 412,120,000 420,291,000 420,291,000 371,788,000 371,788,000 420,631,000 420,631,000 395,417,000 395,417,000 270,657,000 306,477,000 337,582,000 332,712,000           
        other accrued expenses
                                                                                                                                  4,827,000 4,827,000 7,303,000 7,303,000 5,562,000 5,562,000       7,127,000 7,127,000   13,613,000 13,001,000 13,060,000 13,774,000 11,419,000 10,489,000 9,460,000 12,012,000 9,085,000 10,371,000 11,867,000  9,675,000 9,125,000 
        other intangibles
                                                                                                                                          328,000 328,000 2,461,000 2,461,000 2,533,000 2,533,000 2,605,000 2,605,000 2,704,000 2,914,000 3,154,000 3,425,000 3,697,000 3,968,000 4,240,000 4,512,000 3,690,000 3,858,000 3,969,000  4,302,000 4,469,000 
        current portion of capital lease obligations
                                                                                                                                                    8,000 98,000 347,000 731,000 1,357,000 1,931,000 2,177,000 2,679,000 3,408,000  5,552,000 6,432,000 
        convertible promissory note
                                                                                                                                                    30,000,000 30,000,000 30,000,000 30,000,000         
        convertible promissory loans
                                                                                                                                                  85,000,000 85,000,000   85,000,000 85,000,000         
        convertible promissory note and loans
                                                                                                                                                    85,000,000 85,000,000           
        capital lease obligations
                                                                                                                                                        8,000 98,000 297,000 627,000 1,136,000  2,467,000 3,307,000 
        prepaid expense and other current assets
                                                                                                                                                      7,141,000 5,891,000 5,248,000        
        related-party receivables
                                                                                                                                                      7,000 9,000 24,000 51,000     540,000 600,000 
        convertible promissory note and loan
                                                                                                                                                        115,000,000 115,000,000 85,000,000 85,000,000 85,000,000  55,000,000 55,000,000 
        notes receivable from stockholders
                                                                                                                                                                
        deferred stock compensation
                                                                                                                                                                
        other current assets
                                                                                                                                                          6,532,000 5,116,000 3,780,000  4,834,000 5,452,000 
        restricted cash
                                                                                                                                                              18,882,000 12,588,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-01-02 2025-09-30 2025-06-30 2025-04-04 2025-03-31 2024-12-31 2024-09-27 2024-06-28 2024-03-31 2024-03-29 2023-12-29 2023-09-29 2023-06-30 2023-03-31 2022-12-30 2022-09-30 2022-06-30 2022-04-01 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-04-02 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-04-03 2020-03-31 2019-12-31 2019-09-27 2019-06-28 2019-03-31 2019-03-29 2018-12-28 2018-09-28 2018-06-29 2018-03-31 2018-03-30 2017-12-29 2017-09-29 2017-06-30 2017-03-31 2016-12-30 2016-09-30 2016-06-30 2016-04-01 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-04-03 2015-03-31 2014-12-31 2014-09-26 2014-06-27 2014-03-31 2014-03-28 2013-12-31 2013-09-27 2013-06-28 2013-03-31 2013-03-29 2012-12-28 2012-09-30 2012-06-29 2012-03-31 2012-03-30 2011-12-30 2011-09-30 2011-06-30 2011-04-01 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-04-02 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-04-03 2009-03-31 2008-12-31 2008-09-26 2008-06-27 2008-03-31 2008-03-28 2007-12-28 2007-09-28 2007-06-29 2007-03-31 2007-03-30 2006-12-29 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2004-09-30 2004-06-30 2004-03-31 2003-09-30 
                                                                                                                  
          net income
        244,528,000 193,578,000 184,848,000 159,616,000 159,616,000 139,861,000 117,973,000 226,116,000 37,317,000 37,317,000 85,518,000 1,041,000 81,178,000 40,028,000 -30,173,000 73,210,000 70,672,000 68,573,000 68,573,000 95,166,000 38,204,000 96,092,000 1,601,000 1,601,000 28,388,000 -32,040,000 66,821,000 48,612,000 48,612,000 68,743,000 97,452,000 79,042,000 75,775,000 75,775,000 360,089,000 126,630,000 87,494,000 115,857,000 115,857,000 38,489,000 81,382,000 17,656,000 16,700,000     -61,347,000     -35,170,000    -74,619,000  -70,746,000   -44,729,000  -52,193,000 -32,814,000  -26,151,000      -27,490,000           -37,949,000   -41,274,000     -24,201,000               
          adjustments to reconcile net income to net cash from operating activities:
                                                                                                                  
          depreciation and amortization
        6,946,000 7,422,000 7,342,000 7,345,000 7,345,000           5,663,000               2,090,000 2,036,000 1,962,000 1,962,000 2,039,000 1,700,000 805,000 371,000 371,000 345,000 279,000 282,000 281,000 248,000 298,000 227,000 229,000 229,000 343,000 379,000 387,000 297,000 297,000 -623,000 1,921,000 595,000 498,000 498,000 765,000 754,000 786,000 842,000 842,000 1,646,000 1,431,000 1,407,000 1,233,000 1,233,000 1,787,000 1,106,000 2,000,000 1,929,000 1,929,000 2,267,000 2,403,000 2,801,000 3,072,000 3,072,000 3,037,000 3,117,000 3,155,000 3,286,000 3,286,000 3,405,000 3,261,000 3,297,000 3,264,000 3,264,000 3,142,000 2,847,000 2,384,000 2,757,000 2,757,000 3,524,000 3,893,000 4,360,000 4,313,000 4,115,000 4,298,000 4,078,000 4,178,000 4,173,000 3,967,000 4,097,000 4,478,000 4,180,000 
          impairment of long-lived assets
             153,000                                                                                                     
          stock-based compensation
        20,097,000 30,885,000 36,071,000 25,930,000 25,930,000 26,346,000 23,023,000 25,354,000 19,113,000 19,113,000 24,306,000 40,478,000 24,900,000 16,661,000 25,856,000 37,337,000 24,622,000 19,759,000 19,759,000 23,166,000 33,966,000 28,035,000 34,653,000 34,653,000 19,279,000 55,655,000 16,154,000 13,982,000 13,982,000 15,855,000 13,139,000 15,079,000 12,529,000 12,529,000 12,296,000 9,742,000 9,283,000 9,305,000 9,305,000                                                                    
          non-cash lease expense
        6,019,000 6,044,000 6,070,000 6,096,000 6,096,000 6,350,000 7,168,000 7,179,000 6,764,000 6,764,000 7,501,000 7,495,000 7,249,000 6,731,000 6,384,000 5,488,000 5,058,000 1,385,000 1,385,000 1,380,000 1,366,000 1,365,000 1,221,000 1,221,000 1,223,000 1,224,000 1,209,000 1,174,000 1,174,000                                                                              
          deferred taxes
                         15,318,000 15,318,000 14,164,000 9,565,000 26,188,000 -3,388,000 -3,388,000 -538,000 -6,990,000 12,665,000 10,128,000 10,128,000                                                                              
          acquired in-process research and development technology
        5,000,000 6,249,000    19,500,000 11,000,000 750,000 19,500,000 19,500,000 91,000,000 1,000,000 36,500,000                                                                                             
          other
        -2,348,000 1,356,000 -5,831,000 -4,786,000 -4,786,000 -4,379,000 -17,171,000 -1,282,000 9,206,000 9,206,000 -4,425,000 -4,196,000 -4,433,000 -3,743,000 -7,915,000 3,031,000 2,779,000 1,580,000 1,580,000 -12,428,000 13,040,000 16,253,000 6,578,000 6,578,000 1,426,000 883,000 1,614,000 -888,000 -888,000      -935,000 -933,000 -2,212,000 1,722,000 1,722,000 59,000 384,000 466,000 680,000 -1,129,000 -243,000 336,000 -1,474,000 -1,474,000 -11,000 245,000 456,000 637,000 637,000 559,000 987,000 1,140,000 1,475,000 1,475,000 1,544,000 1,601,000 1,909,000 1,733,000 1,733,000 1,539,000 1,084,000 1,062,000 1,304,000 1,304,000 1,164,000 1,855,000 1,304,000 478,000 478,000 819,000 762,000 715,000 938,000 938,000 998,000 426,000 -161,000 356,000 356,000 -63,000 417,000 380,000 212,000 212,000 240,000 229,000 172,000 145,000 145,000 202,000 242,000 175,000 135,000 156,000 157,000 172,000 117,000 203,000 173,000 -508,000 562,000 134,000 
          changes in operating assets and liabilities:
                                                                                                                  
          trade receivables
        22,809,000 -17,370,000 -10,718,000 -16,119,000 -16,119,000  127,025,000 -156,047,000 -3,170,000 -3,170,000 11,181,000 -15,487,000 861,000 -19,178,000 -41,000 20,197,000 -45,100,000 91,793,000 91,793,000 -102,200,000 -7,811,000 5,377,000 -17,690,000 -17,690,000 4,604,000 -45,060,000 16,256,000 -18,270,000 -18,270,000 50,733,000 -72,247,000 10,129,000 55,101,000 55,101,000                                                                         
          inventory
        13,806,000 -4,149,000 2,639,000 -71,000 -71,000 2,762,000 -384,000 1,360,000 1,715,000 1,715,000 1,526,000 -1,688,000 -4,445,000 -8,370,000 -1,847,000 -1,514,000 -4,802,000 -3,520,000 -3,520,000 13,747,000 -18,936,000 -5,930,000 -2,090,000 -2,090,000 -8,431,000 -6,417,000 -2,354,000 -4,695,000 -4,695,000 -2,203,000 -1,014,000 -2,209,000 -305,000 -305,000 595,000 -2,062,000 -808,000 -906,000 -906,000 -851,000 -381,000 -2,121,000 34,000 -46,000 -484,000 -336,000 144,000 144,000 -494,000 486,000 -15,000 -212,000 -212,000 1,495,000 -850,000 -340,000 204,000 204,000 -1,126,000 -1,083,000 -401,000 -280,000 -280,000                                            
          prepaid expenses and other assets
        -97,034,000 47,649,000 -104,706,000 20,320,000 20,320,000 94,147,000 -96,728,000 23,585,000 10,075,000 10,075,000 -32,254,000 -6,118,000 -1,824,000 10,372,000 6,907,000 -9,141,000 -22,420,000 -3,605,000 -3,605,000 -15,623,000 -11,956,000 -14,168,000 1,872,000 1,872,000 -9,963,000 3,086,000 -16,091,000 -2,863,000 -2,863,000                     -1,061,000 2,799,000 -1,846,000 -1,846,000  -3,060,000                                                    
          accrued collaboration liabilities
        355,000 903,000 -3,964,000 4,605,000 4,605,000 854,000 1,347,000 1,479,000 -3,829,000 -3,829,000 264,000 -2,191,000 5,136,000 -1,864,000 1,911,000 -11,713,000 998,000 -54,261,000 -54,261,000                  -261,000 -1,000,000 -1,000,000 -163,000 1,218,000                                                                  
          accounts payable and other liabilities
        -12,900,000 17,755,000 -63,508,000 8,501,000 8,501,000 2,243,000 26,393,000 -16,275,000 -34,247,000 -34,247,000 46,777,000 192,000 5,154,000 1,123,000 19,127,000 -11,188,000 10,527,000 7,376,000 7,376,000 7,278,000 18,977,000 28,697,000 138,000 138,000 -42,000 50,889,000 2,393,000 -2,131,000 -2,131,000                                                                              
          net cash from operating activities
        333,515,000 290,322,000 48,993,000 211,437,000 211,437,000 240,263,000 271,338,000 119,548,000 68,822,000 68,822,000 10,571,000 117,367,000 120,978,000 84,408,000 73,694,000 110,071,000 31,130,000 147,719,000 147,719,000 96,452,000 83,307,000 181,501,000 39,544,000 39,544,000 33,293,000 17,938,000 101,677,000 56,074,000 56,074,000 158,021,000 75,614,000 131,728,000 161,593,000 161,593,000 104,591,000 164,552,000 74,769,000 71,808,000 71,808,000 53,353,000 37,865,000 5,535,000 68,858,000 83,714,000 -6,435,000 -25,879,000 154,896,000 154,896,000 -35,433,000 -34,233,000 -26,833,000 -45,086,000 -45,086,000 -49,976,000 -58,006,000 -55,337,000 -72,086,000 -72,086,000 -47,329,000 -56,995,000 -40,034,000 -54,415,000 -54,415,000 -38,736,000 -34,053,000 -35,391,000 -14,966,000 -14,966,000 -29,174,000 -43,267,000 -43,516,000 -43,276,000 -43,276,000 21,254,000 -43,827,000 -24,736,000 -53,739,000 -53,739,000 -50,750,000 90,706,000 -12,425,000 -42,122,000 -42,122,000 153,821,000 -56,391,000 -67,969,000 -39,218,000 -39,218,000 -24,914,000 -39,356,000 -49,269,000 44,800,000 44,800,000 10,124,000 -34,251,000 -31,246,000 10,034,000 -6,177,000 -32,645,000 24,746,000 -32,285,000      
          capital expenditures
        -1,157,000 -1,482,000 -2,838,000 -2,952,000 -2,952,000 -3,977,000 -8,197,000 -6,570,000 -9,691,000 -9,691,000 -13,135,000 -9,373,000 -5,937,000 -12,024,000 -1,717,000 -9,970,000 -12,337,000 -5,609,000 -5,609,000 -18,364,000 -14,479,000 -20,211,000 -13,557,000 -13,557,000 -14,291,000 -6,091,000 -6,641,000 -2,480,000 -2,480,000 -2,059,000 -1,209,000 -2,307,000 -2,307,000 -15,221,000 -12,235,000 -2,947,000 -2,947,000 -17,694,000 -1,137,000 -1,504,000 -808,000 -587,000 -33,000 -401,000 -682,000 -682,000 -333,000 -20,000 -63,000 -31,000 -31,000 -22,000 -108,000 40,000 -384,000 -384,000 -92,000 -677,000 -673,000 -729,000 -729,000 -1,189,000 -1,019,000 -437,000 -72,000 -72,000 -279,000 -144,000 -163,000 -405,000 -405,000 -330,000 -650,000 -579,000 -252,000 -252,000 -4,316,000 -750,000 -444,000 -398,000 -398,000 -1,207,000 -2,391,000 -6,171,000 -5,363,000 -5,363,000 -3,249,000 -4,749,000 -5,761,000 -3,640,000 -3,640,000 -3,273,000 -1,540,000 -4,740,000 -2,057,000 -3,238,000 -2,859,000 -4,274,000 -3,986,000      
          free cash flows
        332,358,000 288,840,000 46,155,000 208,485,000 208,485,000 236,286,000 263,141,000 112,978,000 59,131,000 59,131,000 -2,564,000 107,994,000 115,041,000 72,384,000 71,977,000 100,101,000 18,793,000 142,110,000 142,110,000 78,088,000 68,828,000 161,290,000 25,987,000 25,987,000 19,002,000 11,847,000 95,036,000 53,594,000 53,594,000 158,021,000 73,555,000 130,519,000 159,286,000 159,286,000 104,591,000 149,331,000 62,534,000 68,861,000 68,861,000 35,659,000 36,728,000 4,031,000 68,050,000 83,127,000 -6,468,000 -26,280,000 154,214,000 154,214,000 -35,766,000 -34,253,000 -26,896,000 -45,117,000 -45,117,000 -49,998,000 -58,114,000 -55,297,000 -72,470,000 -72,470,000 -47,421,000 -57,672,000 -40,707,000 -55,144,000 -55,144,000 -39,925,000 -35,072,000 -35,828,000 -15,038,000 -15,038,000 -29,453,000 -43,411,000 -43,679,000 -43,681,000 -43,681,000 20,924,000 -44,477,000 -25,315,000 -53,991,000 -53,991,000 -55,066,000 89,956,000 -12,869,000 -42,520,000 -42,520,000 152,614,000 -58,782,000 -74,140,000 -44,581,000 -44,581,000 -28,163,000 -44,105,000 -55,030,000 41,160,000 41,160,000 6,851,000 -35,791,000 -35,986,000 7,977,000 -9,415,000 -35,504,000 20,472,000 -36,271,000      
          cash flows from investing activities:
                                                                                                                  
          purchases of marketable securities
        -154,941,000 -189,370,000 -101,485,000 -186,701,000 -186,701,000 -305,383,000                                                           -199,303,000 -46,853,000 -113,368,000 -113,368,000 -26,633,000 -21,144,000 -129,421,000 -60,015,000 -60,015,000 -26,131,000 -37,623,000 -80,000,000 -23,563,000 -23,563,000 -39,277,000 -78,869,000 -38,972,000 -4,048,000 -4,048,000 3,665,000 3,660,000 -4,347,000 -4,932,000 -4,932,000 -30,726,000 -64,897,000 -46,638,000 -61,556,000 -61,556,000 -55,143,000 -8,598,000 -12,821,000 -15,180,000          
          proceeds from maturities and sales of marketable securities
        189,339,000 221,506,000 353,104,000 258,917,000 258,917,000 226,159,000                                                                                                     
          purchases of property, equipment and other
        -1,157,000 -1,482,000 -2,838,000 -2,952,000 -2,952,000 -3,977,000 -8,197,000 -6,570,000 -9,691,000 -9,691,000 -13,135,000 -9,373,000 -5,937,000 -12,024,000 -1,717,000 -8,043,000 -12,337,000 -5,609,000 -5,609,000 -15,960,000 -14,497,000 -20,211,000 -13,557,000 -13,557,000 -14,290,000 -6,130,000 -6,964,000 -2,961,000 -2,961,000                                                                              
          net cash from investing activities
        27,241,000 25,405,000 248,031,000 49,764,000 49,764,000 -93,201,000 -217,147,000 81,772,000 111,793,000 111,793,000 61,737,000 34,685,000 -73,785,000 -49,592,000 -245,782,000 -68,951,000 -135,142,000 -74,539,000 -74,539,000 -13,055,000 -21,239,000 -70,845,000 62,255,000 62,255,000 -29,509,000 -207,600,000 73,274,000 32,620,000 32,620,000 -130,201,000 -206,460,000 -142,929,000 -107,657,000 -107,657,000 -142,799,000 -63,251,000 -66,267,000 -25,533,000 -25,533,000 -18,833,000 -26,591,000 46,716,000 34,503,000 -60,410,000 -12,128,000 -123,825,000 -19,685,000 -19,685,000 24,009,000 -31,512,000 7,685,000 49,895,000 49,895,000 30,176,000 11,105,000 44,689,000 60,360,000 60,360,000 59,505,000 18,026,000 467,000 66,353,000 66,353,000 -99,629,000 -141,206,000 33,643,000 -52,278,000 -52,278,000 37,375,000 32,559,000 -89,895,000 -31,502,000 -31,502,000 6,394,000 -15,192,000 -38,382,000 27,611,000 27,611,000 -8,151,000 -69,391,000 -34,557,000 -223,000 -223,000  50,054,000 8,720,000 29,271,000 29,271,000 7,122,000 4,904,000 9,909,000 -24,954,000 -24,954,000 -44,038,000 21,257,000 -31,444,000 32,524,000 6,738,000 -29,639,000 -24,121,000 10,953,000 -179,000     
          cash flows from financing activities:
                                                                                                                  
          payments for repurchases of common stock
        -257,618,000 -104,035,000 -301,924,000 -283,934,000 -283,934,000 -190,412,000 -11,927,000 -264,319,000 -185,375,000 -185,375,000 -209,296,000 -216,843,000                                                                                               
          proceeds from issuance of common stock under the equity incentive plan and stock purchase plan
        7,875,000     18,823,000 19,789,000                                                                                                    
          taxes paid related to net share settlement of equity awards
        -4,825,000 -3,377,000 -40,502,000 -22,516,000 -22,516,000 -16,445,000 -2,166,000 -13,026,000 -6,988,000 -6,988,000 -5,986,000 -9,747,000 -10,832,000 -2,557,000 -7,209,000 -4,927,000 -6,478,000 -4,686,000 -4,686,000 -24,059,000 -5,636,000 -3,972,000 -5,441,000 -5,441,000 -23,898,000 -5,179,000 -19,148,000 -1,793,000 -1,793,000 -6,535,000 -935,000 -854,000 -1,580,000 -1,580,000 -4,369,000 -229,000 -847,000 -2,129,000 -2,129,000 -3,551,000 -681,000 -788,000 -1,543,000                                                                
          net cash from financing activities
        -254,568,000 -103,860,000 -316,343,000 -294,823,000 -294,823,000 -188,034,000 5,696,000 -262,422,000 -184,048,000 -184,048,000 -206,173,000 -219,673,000 -124,792,000 4,586,000 -2,003,000 -2,038,000 4,422,000 205,000 205,000 -17,994,000 -2,881,000 8,724,000 -2,650,000 -2,650,000 -18,694,000 -3,435,000 -5,148,000 2,145,000 2,145,000 -3,000,000 3,274,000 7,053,000 5,226,000 5,226,000 -1,144,000 3,915,000 7,174,000 -254,000 -254,000 -713,000 2,871,000 -100,218,000 -71,868,000 17,163,000 -45,000 2,649,000 37,000 37,000 7,416,000 149,438,000 -3,890,000 -217,000 -217,000 130,000 -374,000 449,000 65,287,000 65,287,000 -214,000 -789,000 109,000 -10,775,000 -10,775,000 -371,000 415,924,000 -578,000 63,453,000 63,453,000 -155,000 1,639,000 6,640,000 179,389,000 179,389,000 -25,550,000 -2,842,000 162,029,000 -2,376,000 -2,376,000 -24,873,000 -3,657,000 -1,531,000 -3,928,000 -3,928,000 -3,676,000 -4,480,000 12,413,000 -3,627,000 -3,627,000 12,073,000 70,354,000 1,139,000 682,000 682,000 101,915,000 -2,194,000 8,569,000 1,054,000 5,905,000 47,477,000 42,985,000 4,566,000      
          net increase in cash and cash equivalents
        106,188,000        -3,433,000 -3,433,000 -133,865,000                                31,493,000 40,467,000   135,248,000 135,248,000 -4,008,000 83,693,000 -23,038,000 4,592,000 4,592,000   -10,199,000 53,561,000 53,561,000 11,962,000   1,163,000 1,163,000 -138,736,000   -3,791,000 -3,791,000 8,046,000 -9,069,000 -126,771,000 104,611,000 104,611,000 2,098,000 -61,861,000         183,468,000   -13,574,000 -13,574,000 -5,869,000   20,470,000 20,470,000 67,669,000 -15,174,000 -54,084,000 43,630,000 6,461,000 -14,811,000        
          cash and cash equivalents at beginning of period
        217,374,000 217,374,000 262,994,000 262,994,000                                 141,634,000 141,634,000  80,395,000 80,395,000  103,978,000 103,978,000  170,069,000 170,069,000                                            
          cash and cash equivalents at end of period
        106,188,000 211,867,000 -19,319,000 183,752,000 183,752,000 -40,972,000 59,887,000 -61,102,000 259,561,000 259,561,000 -133,865,000 -67,621,000                                 -18,608,000 -147,055,000 276,882,000 276,882,000  83,693,000 -23,038,000 84,987,000 84,987,000  -47,275,000 -10,199,000 157,539,000 157,539,000  -39,758,000 -39,458,000 171,232,000 171,232,000                                            
          supplemental cash flow disclosures:
                                                                                                                  
          net cash paid for income taxes
                                                                                                                  
          non-cash operating activities:
                                                                                                                  
          right-of-use assets obtained in exchange for lease obligations
                3,011,000 28,000   33,977,000 1,595,000    4,893,000 4,893,000 2,193,000 1,248,000 576,000 576,000                                                                              
          impairment of right-of-use assets
                                                                                                                  
          non-cash investing activity:
                                                                                                                  
          unpaid liabilities incurred for purchases of in-process research and development technology
                                                                                                                  
          unpaid liabilities incurred for purchases of investment
                                                                                                                  
          proceeds from issuance of common stock under the equity incentive plans and stock purchase plan
                                                                                                                  
          net decrease in cash and cash equivalents
          -19,319,000 -33,622,000 -33,622,000 -40,972,000 59,887,000                                  14,145,000                                                            -16,721,000      
          proceeds from issuance of common stock under the equity incentive plans
           11,627,000 11,627,000                                                                                                      
          trade receivable
                                                                                                                  
          cash paid for taxes
                                                                                                                  
          depreciation
              7,454,000 7,329,000 6,378,000 6,378,000 6,526,000 6,296,000 6,040,000 6,855,000    4,490,000 4,490,000 1,931,000 4,804,000 3,668,000 3,227,000 3,227,000 2,410,000 2,355,000 2,201,000 2,175,000 2,175,000                                                                              
          purchases of investments
               -108,686,000 -138,468,000 -138,468,000 -78,621,000 -182,519,000 -329,491,000 -311,837,000 -371,305,000 -387,320,000 -355,546,000 -336,545,000 -336,545,000 -279,791,000 -388,474,000 -357,291,000 -331,612,000 -331,612,000 -203,294,000 -433,821,000 -181,649,000 -251,505,000 -251,505,000 -294,984,000 -369,430,000 -278,399,000 -239,869,000 -239,869,000 -189,528,000 -141,292,000 -110,475,000 -116,537,000 -116,537,000 -71,044,000 -93,237,000 -30,315,000 -124,494,000 -110,678,000 -59,113,000 -150,161,000 -49,235,000 -49,235,000 -24,300,000 -73,475,000 -32,935,000 -13,282,000 -13,282,000 -10,291,000 -26,957,000 -46,343,000 -35,937,000 -35,937,000 -13,207,000 -29,017,000 -51,594,000 -96,157,000 -96,157,000                                            
          proceeds from maturities and sales of investments
               215,278,000 268,452,000 268,452,000 153,493,000 311,077,000 263,143,000 310,769,000 237,990,000 326,412,000 232,741,000 267,615,000 267,615,000 282,696,000 381,732,000 306,657,000 407,424,000 407,424,000  232,351,000 261,887,000 287,086,000 287,086,000                                                                              
          proceeds from issuance of common stock under equity incentive plans
                8,315,000 8,315,000    7,143,000  2,889,000 10,900,000 4,891,000 4,891,000   12,696,000 2,791,000 2,791,000    3,938,000 3,938,000                                                                              
          deferred revenue
                    162,000 -707,000 647,000 -1,299,000 -662,000 -1,169,000 -1,169,000 -426,000 2,088,000 -4,076,000 13,422,000 13,422,000 -5,063,000 -5,647,000 809,000 8,850,000 8,850,000      1,819,000 -7,458,000 8,562,000 -2,652,000 -2,652,000 -6,965,000 -7,449,000 -6,980,000 35,139,000 5,247,000 56,043,000 -3,333,000 198,802,000 198,802,000 1,000 -7,000 -2,576,000 -2,576,000 1,264,000 192,000 -116,000 -207,000 -207,000 433,000 -490,000 -7,704,000 -7,110,000 -7,110,000 -7,814,000 -7,813,000 -7,813,000 -18,480,000 -18,480,000 -69,366,000 -124,666,000 -25,099,000 -25,397,000 -25,397,000 35,256,000 -42,911,000 -8,910,000 -26,380,000 -26,380,000 -30,829,000 105,768,000 14,195,000 -3,357,000 -3,357,000 189,116,000 -27,019,000 -27,537,000 -1,780,000 -1,780,000 233,000 -14,168,000 -24,778,000 42,832,000 42,832,000 41,780,000 -12,712,000 -16,354,000 26,753,000 12,873,000 -9,222,000 18,102,000 6,261,000      
          proceeds from issuance of common stock under equity incentive and stock purchase plans
                  9,109,000 6,917,000        6,065,000     5,204,000 1,744,000                                                                                 
          net increase in cash, cash equivalents and restricted cash equivalents
                     39,402,000      65,403,000 59,187,000 119,380,000 99,149,000 99,149,000                                                                                   
          cash, cash equivalents and restricted cash equivalents at beginning of period
                     502,677,000 663,891,000 663,891,000 320,772,000 320,772,000                                                                                   
          cash, cash equivalents and restricted cash equivalents at end of period
                     542,079,000 -174,091,000 39,082,000 -99,590,000 737,276,000 737,276,000 65,403,000 59,187,000 119,380,000 419,921,000 419,921,000                                                                                   
          non-cash investing activities:
                                                                                                                  
          accounts receivable for unsettled investment sales
                                                                                                                  
          net increase in cash, cash equivalents, and restricted cash equivalents
                       39,082,000 -99,590,000 73,385,000 73,385,000                                                                                        
          unpaid liabilities incurred for purchases of property and equipment
                       -1,927,000    -2,404,000 18,000    -1,000 39,000 323,000 481,000 481,000                                                                              
          unpaid liabilities incurred in asset acquisition
                          -5,000,000                                                                                      
          unpaid liabilities incurred for unsettled investment purchases
                                                                                                                  
          proceeds from sale of property and equipment
                                              150,000 10,000 4,000 5,000 -20,000 5,000 107,000 107,000 46,000 5,000 656,000 639,000 639,000 106,000 5,000 5,000 276,000 276,000 103,000                11,000 -7,000 175,000 175,000                             
          proceeds from sales and maturities of investments
                                                                                                                  
          net increase in cash, cash equivalents and restricted cash
                                 -193,097,000 169,803,000 90,839,000 90,839,000  -127,572,000 -4,148,000 59,162,000 59,162,000 -39,352,000 105,216,000 15,676,000 46,021,000 46,021,000                                                                    
          cash, cash equivalents and restricted cash at beginning of period
                                 268,137,000 268,137,000  315,875,000 315,875,000 188,314,000 188,314,000                                                                    
          cash, cash equivalents and restricted cash at end of period
                                 -193,097,000 169,803,000 358,976,000 358,976,000  -127,572,000 -4,148,000 375,037,000 375,037,000 -39,352,000 105,216,000 15,676,000 234,335,000 234,335,000                                                                    
          unpaid liabilities incurred to acquire investments
                                                                                                                  
          principal repayments of debt
                                                                                                                  
          supplemental cash flow disclosure:
                                                                                                                  
          cash paid for interest
                                                                                                                  
          non-cash activities:
                                                                                                                  
          property and equipment deemed to have been acquired in build-to-suit lease
                                                                                                                  
          401(k) matching contributions made in common stock
                                      528,000 1,082,000 2,469,000 2,469,000 464,000 509,000                                                                       
          amortization and other changes in right-of-use assets
                                      704,000                                                                            
          deferred income taxes
                                      23,272,000                                                                            
          gain on other equity investments
                                         -209,000 -209,000                                                                   
          accretion of investments, net and other
                                      -1,051,000 -1,504,000 -1,415,000 -1,415,000                                                                         
          other receivables
                                      -1,192,000 -5,080,000 8,741,000 8,741,000                         1,230,000 -962,000 -344,000 -1,114,000 -1,114,000 -44,000 -424,000 -364,000 27,870,000 27,870,000 -25,536,000 1,709,000 -592,000 125,000 125,000 1,410,000 -1,278,000 1,062,000 4,774,000 4,774,000 -470,000 -4,333,000 -1,447,000 -2,255,000 -2,255,000 434,000 184,000 2,686,000 -3,103,000 -3,103,000 -743,000 -901,000 957,000 18,385,000 18,385,000 -18,674,000 -2,151,000 4,422,000 1,313,000 -454,000 -2,163,000 8,216,000 -8,400,000   1,073,000 792,000  
          current portion of unbilled collaboration revenue
                                      -490,000                                                                            
          prepaid expenses and other current assets
                                      -1,643,000 1,299,000 871,000 871,000 500,000 -1,952,000 -3,477,000 1,900,000 1,900,000 -738,000 -3,579,000 1,930,000 -881,000 1,732,000 -2,491,000 134,000 -985,000 -985,000         -359,000 -359,000 2,529,000 -1,719,000 4,981,000 -4,757,000 -4,757,000 128,000 -1,638,000 14,000 -268,000 -268,000 12,075,000 -2,007,000 1,764,000 -1,279,000 -1,279,000 2,891,000 -1,528,000 1,974,000 -3,403,000 -3,403,000 -4,429,000 -1,739,000 -430,000 -740,000 -740,000 -953,000 1,441,000 -512,000 -1,538,000 -1,538,000 708,000 -277,000 -2,481,000 -915,000 -915,000 1,418,000 -1,349,000 -1,200,000 486,000          
          other long-term assets
                                      -1,505,000 65,000 -4,854,000 -4,854,000 -544,000 -545,000 349,000 -346,000 -346,000 -259,000 170,000 538,000 -19,000                                                                
          accounts payable
                                      -2,731,000 1,317,000 -1,294,000 -1,294,000 2,104,000 287,000 -1,352,000 -183,000 -183,000 3,587,000 -1,049,000 2,388,000 -1,916,000                                                                
          accrued compensation and benefits
                                      7,569,000 1,594,000 -9,592,000 -9,592,000 4,859,000 5,745,000 782,000 -317,000 -317,000 1,159,000 4,359,000 1,065,000 -5,844,000                                                                
          accrued clinical trial liabilities
                                      6,621,000 654,000 4,824,000 4,824,000 -727,000 2,157,000 1,450,000 -4,498,000 -4,498,000 3,668,000 1,501,000 202,000 347,000                                                                
          rebates and fees due customers
                                      -491,000 -2,435,000 4,754,000 4,754,000 3,265,000                                                                        
          accrued collaboration liability
                                      126,000 291,000 137,000 137,000 -978,000         -18,710,000 1,717,000 2,319,000 3,736,000 3,736,000                                                           
          current and long-term deferred revenue
                                      -1,064,000 5,969,000 -1,313,000 -1,313,000                                                                         
          long-term portion of lease liabilities
                                      -690,000 -740,000 7,517,000 7,517,000 -251,000                                                                        
          other current and long-term liabilities
                                      8,231,000 -13,460,000 21,169,000 21,169,000 5,548,000 -13,485,000 8,631,000 1,533,000 1,533,000 -2,289,000 4,742,000 -3,469,000 10,926,000                                                                
          purchases of property and equipment
                                      -2,059,000 -1,209,000 -2,307,000 -2,307,000      -17,694,000 -1,137,000 -1,504,000 -808,000 -587,000 -33,000 -401,000 -682,000 -682,000 -333,000 -20,000 -63,000 -31,000 -31,000 -22,000 -108,000 40,000 -384,000 -384,000 -92,000 -677,000 -673,000 -729,000 -729,000 -1,189,000 -1,019,000 -437,000 -72,000 -72,000 -279,000 -144,000 -163,000 -405,000 -405,000 -330,000 -650,000 -579,000 -252,000 -252,000 -4,316,000 -750,000 -444,000 -398,000 -398,000 -1,207,000 -2,391,000 -6,171,000 -5,363,000 -5,363,000 -3,249,000 -4,749,000 -5,761,000 -3,640,000 -3,640,000 -3,273,000 -1,540,000 -4,740,000 -2,057,000 -3,238,000 -2,859,000 -4,274,000 -3,986,000      
          proceeds from maturities of investments
                                      163,628,000 128,971,000 129,820,000 129,820,000 49,622,000 91,256,000 52,444,000 87,504,000 87,504,000 70,255,000 65,442,000 78,386,000 122,507,000 50,850,000 42,295,000 28,232,000 30,108,000 30,108,000 48,595,000 35,903,000 40,028,000 54,410,000 54,410,000 40,385,000 31,248,000 90,947,000 90,311,000 90,311,000 73,701,000 41,581,000 52,793,000 157,096,000 157,096,000                                            
          proceeds from sale of investments
                                      1,401,000 6,978,000 4,699,000 4,699,000 1,000 1,698,000 3,999,000 6,238,000 6,238,000 37,294,000 2,249,000 17,000 17,000                                                           
          proceeds from other equity investments
                                         209,000 209,000                                                                   
          proceeds from exercise of stock options
                                      4,221,000 3,773,000 6,817,000 6,817,000 1,686,000 3,840,000 4,675,000 1,875,000 1,875,000 1,023,000 3,552,000 3,305,000 9,675,000 16,031,000 7,089,000                                                              
          proceeds from employee stock purchase plan
                                         1,552,000    1,815,000   1,708,000    294,000    509,000 1,000    535,000    389,000 1,000    747,000    1,010,000    1,676,000         1,825,000 1,000    1,516,000   1,083,000   978,000   
          principal payments on financing lease obligation
                                      -12,000 -11,000 -11,000 -11,000                                                                         
          amortization and other right-of-use assets
                                        -7,730,000 -7,730,000                                                                         
          unbilled collaboration revenue
                                        -7,753,000 -7,753,000    -38,014,000 -38,014,000                                                                    
          amortization of right-of-use assets
                                                                                                                  
          loss on extinguishment of debt
                                                 128,000                                                               
          amortization of debt discounts and debt issuance costs
                                               93,000 89,000                                                                
          interest paid in kind
                                                                                                                 
          payments on conversion of convertible notes
                                                   -1,000                                                               
          changes in assets and liabilities:
                                                                                                                  
          trade and other receivables
                                           70,324,000 -75,214,000 -10,755,000 -10,755,000 8,402,000 -46,660,000 -9,122,000 6,541,000 48,921,000 -73,562,000 -7,423,000 -4,938,000 -4,938,000 -1,680,000 288,000 -546,000 1,292,000 1,292,000 -160,000 312,000 -577,000 -516,000 -516,000                                                 
          operating lease right-of-use assets
                                                                                                                  
          purchases of property and equipment and other
                                           -15,221,000 -12,235,000 -2,947,000 -2,947,000                                                                    
          supplemental cash flow disclosure - non-cash investing and financing activity:
                                                                                                                  
          property and equipment deemed to have been acquired under build-to-suit lease
                                                                                                                  
          unpaid liabilities incurred to acquire property and equipment
                                                                                                                  
          changes in warrant fair value
                                                                                                                  
          purchase of restricted cash and investments
                                               -4,500,000 -5,000,000 -2,646,000 -3,504,000 -4,500,000 -2,146,000 -2,004,000 -2,004,000 -3,034,000 1,568,000 -1,500,000 -2,684,000 -2,684,000 41,000 -3,541,000 -4,139,000 -504,000 -504,000 -2,300,000 -1,000 -3,280,000 -504,000 -504,000                                            
          proceeds from maturities of restricted cash and investments
                                               4,000,000 5,000,000 2,146,000 3,504,000 4,500,000 646,000 2,004,000 2,004,000 3,035,000 4,507,000 1,499,000 10,748,000 10,748,000 -43,000 9,620,000 4,179,000 6,598,000 6,598,000 1,300,000 6,100,000 3,221,000 6,647,000 6,647,000                                            
          proceeds from issuance of common stock
                                                      37,000 37,000 -2,000     -3,000 75,646,000 75,646,000           30,000 179,347,000 179,347,000                          49,614,000 8,854,000     8,247,000 
          cash and cash equivalents at beginning of year
                                                 151,686,000                                                                
          cash and cash equivalents at end of year
                                                 -47,967,000 183,179,000                                                                
          stock-based compensation expense
                                                5,289,000 5,027,000 4,713,000 4,566,000 3,603,000 3,558,000 11,185,000 11,185,000 6,557,000 12,026,000 1,734,000 1,660,000 1,660,000 1,552,000 714,000 3,982,000 3,758,000 3,758,000 3,528,000 2,898,000 2,926,000 2,679,000 2,679,000 2,611,000 1,900,000 1,990,000 2,332,000 2,332,000 2,690,000 2,974,000 2,832,000 3,603,000 3,603,000 4,368,000 5,463,000 4,755,000 6,526,000 6,526,000 5,394,000 5,939,000 6,481,000 5,092,000 5,092,000 5,826,000 5,788,000 5,619,000 5,674,000 5,674,000 5,218,000 5,229,000 5,178,000 4,543,000 4,543,000 4,458,000 4,076,000 4,443,000 4,636,000          
          repayment of convertible notes and term loan payable
                                                                                                                 
          payment on conversion of convertible notes
                                                                                                                  
          construction-in-progress deemed to have been acquired under build-to-suit lease
                                                                                                                 
          issuance of common stock in settlement of convertible notes
                                                                                                                  
          accrual of interest paid in kind
                                                 -13,893,000 2,068,000 2,069,000 2,031,000 1,972,000 1,936,000 1,936,000 1,927,000                                                          
          gain on sale of other equity investments
                                                                                                                  
          proceeds from sale of other equity investments
                                                                                                                  
          principal payments on debt
                                                  -80,000,000      -4,164,000 -217,000 -217,000 -376,000 -375,000 -479,000 -10,479,000 -10,479,000 -796,000 -792,000 -791,000 -10,791,000 -10,791,000                                            
          cash flows from operating activities:
                                                                                                                  
          gain on sale of business and other equity investment
                                                        -17,000                                                          
          changes in the fair value of warrants
                                                             76,000 -62,000                                                    
          proceeds from sale of business and other equity investments
                                                                                                                  
          redemption of convertible notes
                                                                                                                  
          net loss
                                                   35,123,000 -6,983,000  -61,347,000     -35,170,000      -74,619,000     -44,729,000     -26,151,000    -27,490,000                -41,274,000     -24,201,000 -25,182,000 -25,197,000 -23,990,000 -27,123,000 -24,522,000 -22,775,000 -9,696,000 -27,411,000 -51,922,000   -28,843,000 -24,995,000 
          adjustments to reconcile net loss to net cash from operating activities:
                                                                                                                  
          accretion of debt discount and debt issuance costs
                                                    -2,417,000                                                              
          gain on sale of equity investment
                                                          -95,000 -95,000                                                      
          change in the fair value of warrants
                                                         549,000 549,000                                                      
          other long term assets
                                                    436,000 -142,000 241,000 241,000                                                           
          accounts payable, accrued compensation and benefits, and other accrued liabilities
                                                    4,527,000 8,956,000 5,333,000 5,333,000                                                           
          clinical trial liabilities
                                                    -794,000 -454,000 -1,936,000 -1,936,000  -2,784,000 1,596,000 -10,569,000 -10,569,000  3,735,000 2,249,000 4,160,000 4,160,000                                                 
          other long-term liabilities
                                                    -322,000 -235,000 -258,000 -258,000 -306,000 -464,000 -615,000 -288,000 -288,000 -671,000 -277,000 -250,000 -229,000 -229,000 -1,160,000 -156,000 -231,000 -143,000 -143,000 -1,512,000 210,000 -199,000 -87,000 -87,000 -404,000 -198,000 -328,000 -232,000 -232,000 -7,064,000 -227,000 -877,000 -152,000 -152,000 -6,581,000 402,000 402,000 483,000 483,000 -4,718,000 1,084,000 499,000 831,000 831,000 505,000 1,164,000 1,667,000 1,097,000 1,097,000 1,310,000 1,326,000 1,670,000 1,709,000 1,725,000 1,801,000 1,341,000 1,612,000 1,157,000 618,000 550,000 550,000 250,000 
          proceeds from sale of equity investments
                                                                                                                  
          supplemental cash flow disclosure - non-cash financing activity:
                                                                                                                  
          restructuring liability
                                                     130,000 -1,057,000 -1,057,000 -1,449,000 -2,410,000 -297,000 -3,024,000 -3,024,000 403,000 298,000 -1,762,000 -1,241,000 -1,241,000 -430,000 -1,971,000 -971,000 -2,378,000 -2,378,000 8,733,000 -1,494,000 -130,000 -1,865,000 -1,865,000 3,583,000   -1,478,000 -1,478,000                                  
          proceeds from equity investment
                                                                                                                  
          accretion of debt discount
                                                      5,285,000 5,285,000 4,840,000 5,303,000 7,216,000 7,675,000 7,675,000 7,708,000 7,510,000 7,328,000 6,988,000 6,988,000 6,845,000 6,652,000 6,479,000 6,314,000 6,314,000 6,128,000 4,147,000 2,284,000 2,193,000 2,193,000 2,089,000 2,084,000 492,000 3,324,000 3,324,000                                  
          accounts payable, accrued compensation, and other accrued liabilities
                                                        -1,114,000 -567,000 3,821,000 -3,416,000 -3,416,000  -6,695,000 5,349,000 -10,254,000 -10,254,000                                                 
          clinical trial liability
                                                                  -84,000 5,636,000                                               
          proceeds from sale of business and other equity investment
                                                                                                                 
          proceeds from exercise of stock options and warrants
                                                        7,124,000     120,000 120,000 47,000 3,000 6,000 16,000 16,000 28,000     731,000 4,079,000 3,832,000 3,794,000 3,794,000 1,630,000 50,000 133,000 871,000 871,000 269,000 2,000 2,000 2,000 11,000 5,000 288,000 6,000 6,000 480,000 1,429,000 3,211,000 3,181,000 3,181,000  159,000 798,000 1,562,000          
          non-cash financing activity:
                                                                                                                  
          issuance of warrants in connection with amendment to convertible notes
                                                             2,762,000 2,762,000                                                 
          restructuring charge for property and equipment
                                                                                                                  
          proceeds from sale of equity investment
                                                          95,000 95,000                                                      
          gain on sale of business
                                                                                 -3,297,000 -4,500,000 -4,500,000                             
          other assets
                                                                -5,000 -5,000      17,000 -1,759,000 -108,000 -116,000 -116,000 -296,000 469,000 118,000 114,000 114,000 -87,000 -19,000 -1,712,000 11,000 11,000 5,313,000 370,000 371,000 370,000 370,000 416,000 345,000 -3,631,000 95,000 95,000 427,000 -118,000 -486,000 2,000 2,000 -30,000 702,000 106,000 -134,000 -11,000 67,000 11,000 -1,089,000     -3,000 
          accounts payable and other accrued liabilities
                                                                  9,343,000 -1,031,000 5,851,000 -5,472,000 -5,472,000                           7,269,000                 
          proceeds from sale of business
                                                                                   4,500,000 4,500,000                             
          proceeds from debt issuance
                                                                                                                  
          gain on warrants
                                                                -1,739,000 -1,739,000                                                 
          restructuring (credit) charge for property and equipment
                                                                       -63,000 38,000 16,000 -195,000 -195,000                                       
          gain on sale of property and equipment
                                                                                                                  
          gain on sale of businesses
                                                                                                                  
          proceeds from sale of businesses
                                                                                                                  
          issuance of common stock for settlement of convertible loan, including accrued interest
                                                                                                                  
          restructuring credit for property and equipment
                                                                                                                  
          net gain on sale of property and equipment
                                                                                                                  
          accounts payable and other accrued expenses
                                                                        3,079,000 2,937,000 -2,736,000 -2,736,000 -3,330,000 -2,411,000 -2,719,000 2,905,000 2,905,000 -8,234,000 2,416,000 -9,776,000 6,150,000 6,150,000 7,703,000 4,401,000 3,925,000 -7,021,000 -7,021,000 1,173,000 3,796,000 -303,000 2,297,000 2,297,000    6,667,000 6,667,000 8,100,000 2,258,000 614,000 1,192,000 2,593,000 1,225,000 3,326,000 -6,789,000      
          proceeds from sales of property and equipment
                                                                        18,000 12,000 847,000 847,000                                       
          proceeds on sale of business
                                                                                 400,000                                
          decrease in restricted cash and investments
                                                                        -36,121,000    2,200,000 2,200,000                                  
          proceeds from maturities of marketable securities
                                                                        95,219,000 80,789,000 60,315,000 60,315,000 7,556,000 50,837,000 39,689,000 26,718,000 26,718,000 32,469,000 23,070,000 38,059,000 33,971,000 33,971,000 43,769,000 635,000 2,425,000 2,938,000 2,938,000 9,000 7,871,000 9,002,000 34,299,000 34,299,000 15,152,000 49,732,000 57,095,000 34,360,000 34,360,000 8,133,000 26,315,000 19,750,000 45,443,000          
          proceeds from convertible notes
                                                                                                                  
          proceeds from note payable and bank obligations
                                                                                                                
          principal payments on notes payable and bank obligations
                                                                        -788,000 -1,648,000 -1,646,000 -1,646,000 -1,631,000 -2,440,000 -798,000 -3,752,000 -3,752,000 -30,690,000 -2,892,000 -2,734,000 -3,247,000 -3,247,000 -31,820,000 -3,659,000 -3,656,000 -3,930,000 -3,930,000 -5,699,000 -4,485,000 -3,636,000 -3,633,000 -3,633,000 -2,857,000 -2,973,000 -3,813,000 -2,499,000 -2,499,000   -33,488,000 -2,842,000 -1,720,000 -2,179,000 -1,724,000 -3,678,000      
          cash and cash equivalents, at beginning of period
                                                                        74,257,000 74,257,000  97,440,000 97,440,000  86,796,000 86,796,000  247,698,000 247,698,000  135,457,000 135,457,000  123,369,000 123,369,000  -15,143,000 96,471,000  78,105,000  111,828,000 
          cash and cash equivalents, at end of period
                                                                        240,665,000 -2,326,000 70,466,000 70,466,000  -9,069,000 -126,771,000 202,051,000 202,051,000  -61,861,000 98,911,000 58,292,000 58,292,000  17,658,000 -48,513,000 201,425,000 201,425,000  -10,817,000 -46,836,000 121,883,000 121,883,000  35,719,000 -38,232,000 143,839,000 143,839,000  -30,317,000 -54,084,000 140,101,000  -14,811,000 43,437,000 61,384,000  9,069,000 -41,399,000 80,323,000 -13,516,000 
          proceeds from issuance of common stock, net of offering costs
                                                                         46,000 64,990,000 64,990,000                                       
          proceeds from exercise of stock options and warrants, net of repurchases
                                                                         197,000 109,000 109,000                                       
          consolidated net income
                                                                            46,296,000         -43,249,000     -38,336,000                        
          impairment of property and equipment, net of proceeds from sales
                                                                                                                  
          loss on deconsolidation of symphony evolution, inc.
                                                                                                                
          purchases of investments held by symphony evolution, inc.
                                                                                      -13,000 -36,000 -36,000 -106,000 -133,000 -173,000 -295,000 -295,000 -444,000 -556,000 -611,000 -669,000 -669,000 -745,000 -810,000 -40,440,000 -343,000 -351,000 -325,000        
          proceeds on sale of investments held by symphony evolution, inc.
                                                                                      2,339,000 2,158,000 2,158,000 3,876,000 4,036,000 5,370,000 3,657,000 3,657,000 8,241,000 6,534,000 6,854,000 4,804,000 4,804,000    4,102,000 3,854,000         
          proceeds on sale of property and equipment
                                                                                                                  
          proceeds on sale of businesses
                                                                                                                  
          decrease (increase) in restricted cash and investments
                                                                                                                  
          proceeds from sale of marketable securities
                                                                                 12,780,000 12,780,000 -7,027,000      27,171,000                      
          proceeds from issuance of stock, net of offering costs
                                                                                                                  
          proceeds from notes payable and bank obligations
                                                                                                   12,367,000 2,424,000 6,107,000        
          repayments, net from deconsolidation of symphony evolution, inc.
                                                                                                                
          cash and cash equivalents, at beginning of year
                                                                                                                  
          cash and cash equivalents, at end of year
                                                                                                                  
          impairment of assets due to restructuring
                                                                             -131,000 388,000 122,000 122,000   7,000 2,474,000 2,474,000                             
          consolidated net loss
                                                                                 -17,865,000   -43,249,000     -38,336,000                         
          restructure liability
                                                                                                                  
          proceeds from sales of marketable securities
                                                                                                                  
          impairment of assets
                                                                                 846,000                                 
          gain on sale of plant trait business and artemis pharmaceuticals
                                                                                                                  
          warrants issued in conjunction with deerfield financing agreement
                                                                                                                
          accretion of deerfield implied interest
                                                                                                                  
          accrued restructuring liability
                                                                                                                  
          increase in restricted cash and investments
                                                                                      108,000 -837,000 -837,000                        
          net decreases in cash and cash equivalents
                                                                                    -28,504,000 -28,504,000  17,658,000 -48,513,000 -46,273,000 -46,273,000                        
          amortization of intangibles
                                                                                                   72,000 72,000 98,000 210,000 240,000 272,000 271,000 271,000 272,000 272,000 278,000 168,000 167,000 166,000 166,000 
          proceeds on sale of plant trait business
                                                                                                                  
          proceeds on sale of artemis pharmaceuticals
                                                                                                                  
          proceeds from the issuance of common stock, net of offering costs
                                                                                                                  
          effect of foreign exchange rates on cash and cash equivalents
                                                                                                         -5,000 -4,000 -173,000 45,000     70,000 
          (increase)/decrease in restricted cash and investments
                                                                                                                  
          non-cash investing and financing activities:
                                                                                                                  
          loss attributed to noncontrolling interest
                                                                                           -2,796,000 -2,681,000 -3,343,000 -3,896,000 -3,896,000 -2,408,000 -8,184,000 -7,460,000 -6,589,000 -6,589,000 -6,863,000 -5,546,000 -5,770,000 -3,518,000 -4,891,000 -5,086,000        
          proceeds from sale of equipment
                                                                                                     6,000            
          proceeds on sale of marketable securities
                                                                                                                  
          net cash provided (used) in investing activities
                                                                                                                  
          payments on capital lease obligations
                                                                                                     -8,000 -90,000 -249,000 -384,000 -634,000 -664,000      
          proceeds from purchase of noncontrolling interest by preferred shareholders in symphony evolution, inc., net of fees
                                                                                                              
          warrants issued in conjunction with the symphony evolution, inc. financing
                                                                                                                  
          changes in restricted cash and investments
                                                                                            840,000 -361,000 1,905,000 1,905,000  840,000 990,000 -273,000 -273,000              
          proceeds from sale of stock, net of offering costs
                                                                                                                  
          proceeds from employee stock purchase plans
                                                                                                                 
          effect of foreign exchange rate changes on cash and cash equivalents
                                                                                                 -183,000 -11,000 -58,000 -58,000  14,000 37,000 18,000          
          loss on the sale of equipment
                                                                                                     -17,000 -3,000            
          change in restricted cash and investments
                                                                                                     1,586,000 -216,000 1,119,000 559,000 840,000 1,231,000 727,000 560,000      
          amortization of intangible assets
                                                                                                 51,000                 
          income from the sale of equipment
                                                                                                   5,000               
          proceeds from purchase of noncontrolling interest by preferred stockholders in symphony evolution, inc.
                                                                                                                  
          warrants issued in conjunction with the symphony evolution, inc. transaction
                                                                                                        5,684,000        
          loss from the sale of equipment
                                                                                                    5,000              
          proceeds from maturities of long term marketable securities
                                                                                                   2,020,000 2,020,000              
          acquired in-process research and development
                                                                                                             25,981,000    
          cash paid for acquisitions, net of cash acquired
                                                                                                                  
          repayment of notes from stockholders
                                                                                                             53,000 74,000 
          proceeds from sale of investments held by symphony evolution, inc.
                                                                                                      6,106,000            
          principal payments on notes and bank obligations
                                                                                                                  
          gain on the sale of equipment
                                                                                                          -16,000 -122,000      
          related-party receivables
                                                                                                         3,000 15,000 27,000 28,000 40,000   65,000 
          stock compensation expense
                                                                                                          28,000 23,000 -16,000   42,000 33,000  
          non-cash portion of restructuring charge
                                                                                                                  
          prepaid expense and other current assets
                                                                                                          -1,249,000 -669,000 -925,000      
          cash received from acquisition, net of cash paid
                                                                                                                  
          proceeds on sale of equipment
                                                                                                          1,000 152,000      
          proceeds from maturities of short-term investments
                                                                                                          10,618,000 35,026,000 35,512,000 19,482,000 64,596,000 24,773,000 29,307,000 52,017,000 
          purchases of short-term investments
                                                                                                          -41,092,000 -15,596,000 -21,285,000      
          proceeds from exercise of stock options, net of repurchases
                                                                                                          426,000 609,000 54,000  542,000 1,268,000 721,000 8,000 
          loss from discontinued operations
                                                                                                                  
          proceeds from sale of investments before maturity
                                                                                                                  
          proceeds from bank obligations
                                                                                                             4,849,000 7,457,000   5,933,000 
          property and equipment acquired under capital leases
                                                                                                                  
          stock compensation expense, net of reversals
                                                                                                                 167,000 
          other current assets
                                                                                                                  
          cash from acquisition
                                                                                                                 
          changes in restricted cash
                                                                                                                  
          net cash provided by financing activities
                                                                                                                  
          net cash provided by investing activities
                                                                                                                72,000  
          accrued merger and acquisition costs
                                                                                                                  
          change in restricted cash
                                                                                                                  
          net cash from (used in) investing activities
                                                                                                                  
          principal payments on capital lease obligations
                                                                                                                  
          net cash used in operating activities